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Abstract 
Oligonucleotide-directed triple helix formation is one of the most 
versatile methods for the sequence specific recognition of double helical 
DNA. Chapter 2 describes affinity cleaving experiments carried out to assess 
the recognition potential for purine-rich oligonucleotides via the formation 
of triple helices. Purine-rich oligodeoxyribonucleotides were shown to bind 
specifically to purine tracts of double helical DNA in the major groove 
antiparallel to the purine strand of the duplex. Specificity was derived from 
the formation of reverse Hoogsteen G•GC, A•AT and T•AT triplets and 
binding was limited to mostly purine tracts. This triple helical structure was 
stabilized by multivalent cations, destabilized by high concentrations of 
monovalent cations and was insensitive to pH. A single mismatched base 
triplet was shown to destabilize a 15 mer triple helix by 1.0 kcal/mole at 25°C. 
In addition, stability appeared to be correlated to the number of G•GC triplets 
formed in the triple helix. This structure provides an additional framework 
as a basis for the design of new sequence specific DNA binding molecules. 
In work described in Chapter 3, the triplet specificities and required 
strand orientations of two classes of DNA triple helices were combined to 
target double helical sequences containing all four base pairs by alternate 
strand triple helix formation. This allowed for the use of oligonucleotides 
containing only natural 3' -5' phosphodiester linkages to simultaneously bind 
both strands of double helical DNA in the major groove. The stabilities and 
structures of these alternate strand triple helices depended on whether the 
binding site sequence was 5'-(purine)m (pyrimidine)n -3' or 5'-
(pyrimidine)m (purine)n -3' . 
In Chapter 4, the ability of oligonucleotide-cerium(III) chelates to direct 
the transesterfication of RNA was investigated. Procedures were developed 
vii 
for the modification of DNA and RNA oligonucleotides with a hexadentate 
Schiff-base macrocyclic cerium(III) complex. In addition, oligoribonucleotides 
modified by covalent attachment of the metal complex through two different 
linker structures were prepared. The ability of these structures to direct 
transesterification to specific RNA phosphodiesters was assessed by gel 
electrophoresis. No reproducible cleavage of the RNA strand consistent with 
transesterification could be detected in any of these experiments. 
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Chapter 1 
Introduction 
Deoxyribonucleic acid (DNA) is the primary genetic material 
controlling the inheritance of traits and is the template coding for all the 
proteins and RNA necessary for cellular function.! DNA typically adopts a 
regular right-handed double helical secondary structure (B form), although 
other conformational families exist.2 Structural heterogeneity in DNA arises 
from a local variation in the sequence of base pairs. Therefore, the sequence 
of double helical DNA provides an estimate for its structure at that location. 
Because of the essential functional roles of DNA and its regularity in 
secondary structure, it is an attractive target for the chemist who wishes to 
design molecules which bind specifically to an important biological receptor 
and control its function.3 In addition, synthetic reagents which bind to 
defined sites and cleave the DNA molecule at those sites complement 
existing restriction enzymes for the manipulation of DNA fragments in 
cloning and sequencing protocols by offering the possibility of greater 
specificity.4 For these reasons, the generation of DNA binding molecules 
which can specifically recognize predetermined sequences under 
physiologically relevant solution conditions is a worthwhile endeavor and 
the primary goal of the studies in this thesis. 
The DNA double helix. Analysis of double helical DNA structure can 
provide insight into how sequence specific recognition might be achieved. 
Duplex DNA arises through the formation of hydrogen bonded base pairs 
between two polydeoxyribonucleotide strands creating a cylindrical grooved 
2 
structure.S The major and minor grooves have different hydrogen bonding 
sites and van der Waals surfaces depending on the identity of the base pair at 
that site (Figure 1.1). For instance, the major groove at a GC base pair contains 
two hydrogen bond acceptors (guanine-N7 and 06) and a hydrogen bond 
donor (cytosine-NH2-4). In contrast, the major groove at an AT base pair has 
the hydrogen bond acceptors adenine-N7 and thymine-04, the hydrogen bond 
donor adenine-NH2-6 and the thymine CS methyl group. A given DNA 
sequence can therefore be distinguished by the array of functional groups it 
displays in the grooves of the double helix (Figure 1.2). 
Minor groove Minor groove 
GC AT 
Figure 1.1 Watson Crick base pairs. 
The design of new sequence specific binding molecules is aided by 
principles learned from structural analyses of complexes of DNA with 
proteins and natural products. It is apparent from these studies that sequence 
specific DNA binding arises from the ability of these molecules to form 
specific hydrogen bonds or van der Waals contacts with functional groups in 
the grooves, by Coulombic attraction to the negatively charged 
phosphodiesters and through intercalation of aromatic functional groups 
3 
Figure 1.2 Model of the structure of B form double helical DNA of the 
sequence (5'-CGCGAATTCGCG-3')2.6 Atoms of the bases are colored 
individually by atom type (O=red, N=blue, C=green, and H=white). The 
phosphodiester deoxyribose backbones are colored light blue. Each sequence 
of double helical DNA can be distinguished by the array of functional groups 
it displays in the grooves. 

5 
between the DNA bases. Some or all of these binding modes are used in 
combination to accomplish high affinity sequence specific binding. 
Sequence specific DNA binding proteins. Sequence-specific recognition 
of double helical DNA by proteins is achieved through the assembly of 
structural motifs within the protein which place amino acid side chains in 
the correct relative positions to interact through hydrogen bonding or van der 
Waals contacts to functional groups in the grooves or by salt bridges to the 
negatively charged phosphodiester backbone.7 Several motifs have been 
identified which serve this purpose including the helix turn helix,8 the 
leucine zipper9 and the zinc finger.1 0 Side chain interactions with DNA, 
such as the binding to GC base pairs by arginine or histidine found for the 
Zif268 zinc finger protein-DNA complex, show how hydrogen bonding to 
recognition sites in the grooves can be used to engender sequence specificity 
(Figure 1.3).10 
Figure 1.3 Specific amino acid-base contacts found in the Zif268 zinc finger 
DNA binding protein-DNA complex.10 Secondary structural elements in 
DNA binding proteins position amino acid side chains for interaction with 
bases and phosphodiesters. 
In addition, aliphatic amino acids such as alanine have been shown to make 
van der Waals contacts with thymine methyl groups. Arginine is often 
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found ion paired with DNA phosphodiesters. Also, aromatic residues such as 
phenylalanine can interact with the duplex through stacking by inserting 
between adjacent base pairs. 
These studies provide information about how DNA structure can 
direct sequence specific binding, however, it appears that properly folded 
secondary structural elements are necessary to orient the side chains of DNA 
binding proteins to interact with the necessary DNA functional groups. In 
several cases the binding domains of DNA binding proteins have been 
synthesized and shown to bind specifically to the native binding site.11 
However, the design of new proteins that recognize sequences different from 
the native binding site requires not only the proper selection of amino acids 
for recognition but also the ability to control folding such that the side chains 
are positioned properly. Therefore, protein design is a challenging approach 
to the generation of new sequence specific DNA binding molecules. It 
remains to be seen if truly new sequence specificities can be engineered into 
designed DNA binding proteins. 
DNA binding natural products. Several natural products have been 
isolated that are capable of binding to DNA sequence specifically.12 These 
include the minor groove binders distamycin (Figure 1.4), netropsin, and 
Hoechst 33258, the minor groove binding intercalators actinomycin and 
echinomycin and the ene-diyne family of antitumor antibiotics. Where 
structural studies have been reported, these molecules are shown to bind by 
intercalation and/or specific hydrogen bonding and van der Waals contacts in 
the minor groove. For instance, x-ray crystallographic13 and NMR14 studies 
show that distamycin binds either as a 1:1 complex with DNA or as a 2:1 side 
by side antiparallel dimer at sites containing four to five consecutive A,T base 
pairs. Specificity is derived from the formation of bifurcated hydrogen bonds 
7 
between the carboxamide NH's in the natural product with adenine N3 and 
thymine 02 in the minor groove. Additional specificity arises from the shape 
complemenarity between the crescent shaped natural product and the minor 
groove at A,T-rich sites. 
Distamycin 
Figure 1.4 Structure of the minor groove binding natural product distamycin 
The sequence selectivity demonstrated by distamycin has been 
exploited to design new molecules with new recognition properties. The 1:1 
model for distamycin led to the design of oligomeric distamycin analogs 
capable of recognizing longer tracts of A,T rich DNA.15 The presence of the 2-
amino group of guanosine in the minor groove at G,C base pairs presented a 
steric block to these molecules and therefore binding was limited to A,T sites. 
However, substitutions for the terminal N-methylpyrrole ring of distamycin 
by 1-methylimidazole or pyridine generated synthetic molecules capable of 
recognizing the double helical sequence 5'-TGTCA-3' as 2:1 side by side 
dimers.16 The systematic alteration of the specificities of minor groove 
binding natural products through synthesis continues to be a productive 
method for generating new sequence specific DNA binding molecules. 
Oligonucleotide-directed triple helix formation. Currently the most 
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versatile method for the sequence specific recognition of DNA is through 
triple helix formation. Synthetic oligonucleotides are capable of binding to 
tracts of intact double helical DNA through the formation of a local triple 
helical structure.J7,18 Specificity arises from the formation of base triplets, 
where hydrogen bonding occurs between bases in the oligonucleotides and 
the duplex base pairs. The ability to target a broad range of DNA sequences, 
the high stabilities of the resulting triple helices and the sensitivity to 
mismatches makes this a powerful technique for binding single sites in large 
segments of double helical DNA. However, sequence limitations as well as 
limitations on the solution conditions under which these structures can form 
do exist. Overcoming these limitations by the design of modified 
oligonucleotides is a current area of intense investigation.19 
Triple helical nucleic acid structures were discovered over 30 years ago 
when Felsenfeld, Davies and Rich demonstrated that poly (U) bound to poly 
(A) in a two to one stoichiometry in the presence of MgCl2.20 Shortly 
thereafter, poly (C) was shown to form a two to one complex with guanosine 
oligoribonucleotides at low pH.21 Further work on polymeric nucleic acids 
demonstrated that poly(dT-dC) or poly(U-C) associated with poly(dG-
dA)•poly(dC-dT) at acidic pH to form a three stranded complex.22 Formation 
of isomorphous T(U)•AT(U) and C+GC triplets were proposed to rationalize 
the binding mode for the third strand in these complexes (Figure 1.5). The 
apparent requirement for protonation of cytosine explained the necessity for 
acidic pH for formation of triple helices containing this base. X-ray diffraction 
studies with fibers of poly(U)2poly(A) and poly(dT)2poly(dA) suggested an A ' 
helical conformation with the third strand bound parallel to the purine 
strand of the underlying duplex and anti conformations for the bases.23 The 
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C.GC 
Figure 1.5 Isomorphous T•AT and C+GC triplets 
affinity cleaving experiments of Moser and Dervan demonstrated 
unambiguously that pyrimidine oligonucleotides bind in the major groove 
parallel to the purine strand of double helical DNA.17a This work also 
showed that pyrimidine oligonucleotides equipped with the cleaving 
function EDTA•Fe could bind to a 15 bp site within a 4 kbp plasmid and 
cleave the DNA at that site. 
The ability of pyrimidine oligonucleotides to bind uniquely to sites of 
15-16 bp suggested that these molecules might have the necessary sequence 
selectivity to bind to one site in genomic DNA.24 Indeed, pyrimidine 
oligonucleotides have been used to mediate single site specific cleavage of 
human chromosomal DNA.4 Triple helix formation has also been shown to 
block access to DNA by DNA binding proteins such as methylases, 
transcription factors and polymerases in vitro, suggesting that they might be 
functional in controlling gene expression in vivo.17e,18j 
Triple helices formed by pyrimidine oligonucleotides have been 
studied extensively in recent years. 1H NMR spectroscopy has confirmed the 
structures of the hydrogen bonded base triplets and has been used to 
determine sugar puckering in the deoxyribose backbones.25 A kinetic analysis 
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of the binding of a 21 mer pyrimidine oligonucleotide suggests that triple 
helix formation is a slow process (pseudo first order rate constant of 1.8±0.2 x 
103 M-1s-1), but the formed complex is long lived (half life of- 12 hours).17i 
Thermodynamic studies indicate that stability is highly dependent on 
solution conditions, with binding free energies varying from 6 to 10 
kcal/mole depending on the conditions chosen.17q,r Oligonucleotide binding 
has been shown to be sensitive to single base mismatches and the extent of 
destabilization is dependent on the identity of the mismatched triplet.17f,q 
The triple helical structures are stabilized by polycations such as spermine or 
Co(NH3)6+3,17a The formation of triple helices with C+GC triplets requires 
acidic pH.17a,r Extension of the pH range for triple helix formation at GC rich 
sites has been accomplished through methylation of cytosine at C517c and 
through the use of nonnatural base triplets. 17m, 19g-i Oligonucleotide 
binding appears to be limited to purine tracts of duplex DNA, since stabilizing 
base triplets form only with GC and AT base pairs. This sequence limitation 
has been partially alleviated through the use of G•TA triplets,17f nonnatural 
base triplets17m,19k,l and alternate strand triple helix formation by 3'-3' or 5'-
5' linked pyrimidine oligonucleotides.l7j, 19a,b,d However, a general 
solution to the recognition of any DNA sequence by triple helix formation 
still requires effective methods for specifically recognizing TA and CG base 
pairs within this structure. 
The triple helices formed by pyrimidine oligonucleotides constitute 
one of two different families of triple helical structures. A second class of 
triple helices is introduced and discussed in Chapter 2. This structure differs 
from that formed by pyrimidine oligonucleotides in the base composition of 
the third strand, the relative orientations and positions of the three strands 
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and the base triplet interactions. Formation of this structure is also 
dependent on solution conditions and duplex sequence. 
DNA affinity cleaving and footprinting. Studies of DNA binding 
molecules such as triple helix forming oligonucleotides are aided by the 
techniques of DNA footprinting26 and affinity cleaving27 (Figure 1.6). 
Properties such as binding site size and orientation of the DNA binding 
molecule can be determined through the use of these experiments. Also, 
with the development of quantitative DNase I footprinting28 and 
quantitative affinity cleaving,17q binding free energies can be determined for 
DNA binding molecules under a variety of solution conditions. 
DNA affinity cleaving has become a standard technique for assessing 
binding properties of DNA binding molecules. This method involves the 
covalent attachment of a nonspecific DNA cleaving function to a sequence 
specific DNA binding molecule to generate a sequence specific DNA cleaving 
molecule. EDT A • Fe is useful as the nonspecific cleaving function, since it 
generates a diffusible oxidant (presumably hydroxyl radical) which initiates 
cleavage of the deoxyribose backbone at nearby locations in the bound 
complex. This cleavage is sequence independent and therefore information 
about the sequence selectivity and binding orientation of the covalently 
attached molecule can be determined by locating the cleavage sites using 
sequencing gels. The groove location of the EDTA•Fe in the bound complex 
can be determined from analysis of the pattern of cleavage bands. If EDTA•Fe 
is located in the major groove of right handed double helical DNA, the major 
sites of cleavage are asymmetrically shifted in the 5' direction, whereas if the 
cleaving function is located in the minor groove, the major cleavage sites are 
3' shifted (Figure 1.7). Also, it has been shown that the amount of cleavage 
detected is proportional to the fractional occupancy of the binding site.17q 
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Footprinting 
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Affinity cleaving 
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Figure 1.6 Schematic description of DNA footprinting and affinity cleaving. 
Footprinting involves treatment of 32p labeled DNA with nonspecific 
cleavage reagents in the presence and absence of the DNA binding molecule. 
The cleavage products are separated by polyacrylamide gel electrophoresis 
along with the products of sequencing reactions. Autoradiography reveals 
the location and size of the binding site as positions protected from cleavage 
(Middle, lanes 1 and 2). Affinity cleaving requires the use of DNA binding 
molecules covalently attached to a nonspecific DNA cleaving moiety (*). The 
binding site location and binding orientation are indicated by the location of 
the cleaved nucleotides (Middle, lanes 3 and 4). 
Major groove 
3' 5' 
3' 5' 
13 
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5'-NNNNNNNJ'JNNNNNN -3' 
3'-~+~NNNNN~ttFN -s· 
Minor groove 
5' 3' 
5' 3' 
~H~ 
5'-NNNNNNNNNNNNNN -3' 
3'-NNNNNNNNNNNNNN -5' 
tttt 
Figure 1.7 Cleavage patterns generated by EDTA•Fe located in the major or 
minor grooves of right handed double helical DNA. Circles and arrows indicate 
cleavage sites. 
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This allows for a qualitative assessment of differences in binding affinities for 
DNA binding molecules modified with EDTA•Fe by measuring differences 
in cleavage efficiencies. In addition, use of the quantitative affinity cleavage 
titration can yield the binding free energies for triple helix forming 
oligonucleotides.17q 
Oligonucleotides are readily functionalized with EDTA • Fe for affinity 
cleaving studies through automated DNA synthesis using a protected 
thymidine-EDTA(T*) phosphoramidite (Figure 1.8).29 
Figure 1.8 Structure of the thymidine-EDTA (T*) phosphoramidite 
Description of this work. Chapter 2 of this thesis introduces a second 
structural motif for the recognition of double helical DNA based on triple 
helix formation with purine oligonucleotides. Affinity cleaving experiments 
were carried out to define properties of this triple helical structure such as 
relative strand orientations, specificity and sensitivity to solution conditions 
and sequence constraints. Results from these studies led to the publication of 
reports in Science30 and Nucleic Acids Research.31 In Chapter 3, this triple 
helical structure is used in tandem with the pyrimidine triple helix to bind 
sequences of double helical DNA containing all four base pairs by alternate 
strand triple helix formation. A study on the alternate strand triple helix 
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including most of the data presented in this chapter was reported in the 
Journal of the American Chemical Society.32 Chapter 4 describes some 
exploratory studies on the use of oligonucleotides covalently attached to a 
hexadentate Schiff-base macrocyclic cerium(III) complex for the sequence 
specific transesterification of RNA. This project is ongoing in the Dervan 
laboratories. 
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Chapter 2 
A Second Structural Motif for the Recognition of 
Double Helical DNA by Triple Helix Formation 
21 
Introduction 
Early work on homopolymers of DNA and RNA suggested that in 
addition to triple helical nucleic acid structures comprised of two pyrimidine 
strands and one purine strand (a pyrimidine motif), there existed structures 
comprised of two purine strands and one pyrimidine strand (a purine motif). 
Shortly after Felsenfeld, Davies and Rich discovered that poly(U) bound to 
poly(A) to form a stable 2:1 complex in the presence of MgClz, Lipsett showed 
that GpGpG bound to poly(C) in a 2:1 stoichiometry.l It was proposed that the 
(GpGpG)z(poly(C)) structure was triple helical and was generated through the 
formation of G•GC triplets (Figure 2.1). Later, Marek and Theile demonstrated 
that the deoxyribo homopolymers poly(dG) and poly(dC) could form 
(poly(dG))z(poly(dC) at pH 8.2 
:::1.. 
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Figure 2.1 (Left) UV mixing curve for GpGpG + poly(C) (Right) G•GC base 
triplet proposed by Lipsett.l 
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More recently, Fresco reported that poly(A) of specific degrees of 
polymerization bound to (poly(A))(poly(U)) to form (poly(A))l(poly(U)). 
Interestingly, only poly(A) of length 28-150 formed this triplex structure.3 
Studies of purine tracts in plasmid DNA also suggested that triple helices 
with two purine strands formed. Kohwi-Shigematsu carried out extensive 
chemical reactivity studies on a poly(dG)poly(dC) tract under torsional stress in 
supercoiled plasmid DNA.4 The results indicated that this sequence can adopt 
two nonB DNA conformations depending on the solution conditions (Figure 2.2). 
In the absence of Mg+2 and at acidic pH, the nucleotides in the 5' half of the dG 
strand and at the center of the dC strand reacted with reagents specific for single 
stranded DNA. However, in the presence of Mg+2, the nucleotides in the 5' half 
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Figure 2.2 Models for nonB DNA conformations adopted by poly(dG) tract in 
plasmid DNA proposed by Kohwi-Shigematsu.4 
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of the dC strand and at the center of the dG strand were reactive. Two triple 
helices were proposed to explain these data; one with the dC strand folded back 
parallel to the dG strand of the WC duplex forming H-form DNA with C+GC 
triplets, the other with the dG strand folded back upon itself in an antiparallel 
fashion forming G•GC triplets. 
Evidence that a purine-rich oligonucleotide could bind site specifically to 
duplex DNA was first provided by Hogan and co-workers when they 
demonstrated that a guanosine-rich 27 mer bound to a duplex sequence present 
in the c-myc promoter (Figure 2.3).5 Binding of this oligonucleotide to the 
promoter repressed transcription of the c-myc gene in vitro, demonstrating the 
potential utility of this structure. The binding of this oligonucleotide was 
proposed to be due to the formation of G•GC and A• AT triplets with the third 
purine-rich strand parallel to the purine strand of the duplex (Figure 2.3). 
Although these authors did not present hydrogen bonding models to explain the 
sequence specific binding, it was suggested that the triplets formed may be 
similar to the base triplets found stabilizing tertiary structure in tRNAs. The 
third strand orientation was based on that found for the (poly(dT)h(poly(dA)) 
triple helix. 
142 
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Figure 2.3 Sequence of 27 mer G rich oligonucleotide PUl designed by Hogan 
to bind via triple helix formation in the c-myc promoter.S 
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Triplet Models. The sequence specificity of triple helix formation derives 
from the formation of hydrogen bonded base triplets. It is therefore of primary 
importance to understand the nature of these triplets. In the earliest work on the 
formation of purine motif triple helices, Lipsett proposed the formation of G•GC 
triplets with the third strand guanosine bound to a GC base pair by hydrogen 
bonding (Figure 2.1).1 In this model, the N2 exocyclic amino group and the N1 
NH of the third strand guanosine were hydrogen bonded to the guanosine of the 
Watson-Crick (WC) base pair at N7 and 06 respectively. This type of G•G 
interaction places the sugars of the nucleotides in similar relative positions as 
seen for the Hoogsteen T • A interaction and has therefore been referred to as a 
Hoogsteen G•G interaction (Figure 2.4).6 The Hoogsteen G•G interaction is 
found in guanine quartets(G-quartets), which form with telomeric DNA 
sequences. 7 
Kohwi-Shigematsu proposed a different G•GC triplet with the N2 
exocyclic amino group and N1 NH of the third strand G bound to the G in the 
WC base pair at 06 and N7, respectively (Figure 2.2).4 This G•G interaction 
places the sugars in relative positions similar to that in the reverse Hoogsteen 
T•A interaction and is referred to as reverse Hoogsteen (Figure 2.4).6 Reverse 
Hoogsteen G•G hydrogen bonding is found in crystal structures of guanine and 
guanosine and has been calculated to be the most stable G•G interaction in 
chloroform.8,9 In addition, Williams et al. showed by NMR that the reverse 
Hoogsteen bonded G•GC triplet was more stable than the Hoogsteen bonded 
G•GC triplet in chloroform.IO Importantly, the crystal structure of yeast 
tRNAPhe revealed that the tertiary fold of this tRNA has a reverse Hoogsteen 
bonded rn7G46•G22•C13 triplet, with the strands containing the rn7G46 and G22 
in an antiparallel orientation (Figure 2.5).11 Klug et al. note that this triplet is 
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Hoogsteen G•G Hoogsteen T • A 
reverse Hoogsteen G•G reverse Hoogsteen T • A 
Figure 2.4 Guanine-guanine hydrogen bonding schemes; termed Hoogsteen or 
reverse Hoogsteen based on their relation to the thymine-adenine hydrogen 
bonding identified by Hoogsteen in crystals of 9-methyladenine and 1-
methylthymine (upper right).6 
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highly conserved in class I type tRNAs with only yeast tRNAArg having different 
nucleotides at positions 13, 22 and 46. It was suggested that tRNAArg, which has 
a Ul3, A22, and A46 sequence, might maintain the proper folding by forming an 
A46•A22•U13 triplet, which is nearly isomorphous to the m7G46•G22•C13 
triplet in tRNAphe (Figure 2.5). 
m 7G46•G22C13; found in tRNAPhe 
Figure 2.5 Base triplets in tRNA 
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Therefore, the sequence specificity for purine motif triple helix formation 
can be rationalized based on models for G•GC and A•AU triplets. In addition, 
models for Hoogsteen and reverse Hoogsteen G•GC triplets have sugar-
phosphodiester backbone positions similar to Hoogsteen and reverse Hoogsteen 
bonded T•AT triplets, suggesting that T•AT and G•GC triplets may be 
compatible. 
Results and Discussion 
Orientation. At the initiation of this work, the relative strand orientations 
in the purine motif triple helix had not been determined. Hogan and co-workers 
had designed an oligonucleotide to bind via G•GC and A•AT triplets with the 
third strand parallel to the purine rich strand of the duplex target.S However, 
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Maher et al. were unable to confirm this parallel purine-rich model when they 
could not detect binding by a purine oligonucleotide to a homopurine target 
site.l2 Moreover, Griffin and Dervan found that guanine in an otherwise 
pyrimidine oligonucleotide bound to a TA base pair rather than a GC base pair, 
suggesting that two different structural motifs may exist for triple helical 
recognition.l3 Additionally, Kohwi-Shigematsu had proposed a model for a 
G•GC containing triple helix in a supercoiled plasmid with the two purine 
strands antiparallel. 4 
Since both a parallel and antiparallel orientation of the third strand had 
been proposed in the literature for purine motif triple helices, it was necessary to 
define this parameter before further studies with this structure could be 
undertaken. Affinity cleaving experiments were designed to address this issue. 
We chose as our initial double helical binding site the 19 bp purine 
sequence, 5' -AGGGAGGGGAGGGGAGGGA-3 within a 39 bp oligonucleotide 
duplex. Since this is a symmetrical sequence, which is identically read from 3' to 
5' or 5' to 3', it could, in principle, support two triple helical structures with the 
third strand bound parallel or antiparallel to the WC purine strand. Considering 
the models for possible base triplet interactions in the purine motif, we reasoned 
that in addition to guanine recognition of GC base pairs, AT base pairs might be 
recognized by adenines or thymines in the third strand. Given this specificity 
hypothesis, oligonucleotides 1 and 2 of sequence composition 5'-
T*GGGXGGGGXGGGGXGGGT-3'(where X = T or A) were prepared by 
automated synthesis with thymidine-EDT A (T*) at each 5' end such that DNA 
binding could monitored by the affinity cleaving method (Figure 2.6).14 
In the presence of Fe(ll) and DTT, these oligonucleotides cleaved both 
strands of the target duplex near the 3' end of the purine tract (2 ~-tM, pH=7.8, 
24°C). The cleavage maximum on each strand was shifted 2-5 bases in the 5' 
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~~~GGXGGGGXGGGGXGGGT~ 
or 
3'-TGGGXGGGGXGGGGXGGGP-5' 
3~~AATT8I8I8Ittt~tgggtggggtggggtggg~tttt8I8I8IGATc~ 3~ 
l:X=T 2:X=A 
Figure 2.6 Sequences of oligonucleotidesEDTA 1 and 2 with symmetrical 
duplex target sequence (boxed) for determination of preferred third strand 
orientation 
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Figure 2.7 (A and B) Autoradiograms of 20% denaturing polyacrylamide gels 
used to separate cleavage products. The cleavage reactions were carried out by 
combining a mixture of oligonucleotide-EDT A (2 J.LM) and Fe(II) (5 J.LM) with the 
32P-labeled oligomer duplex[- 20,000 cpm] in a solution of TrisOAc pH=7.8 (50 
mM), NaCl(lO mM), spermine, and calf thymus DNA(lOO J.LM in base pairs) and 
then incubating at 24° C for 1 hour. Cleavage reactions were initiated by the 
addition of dithiothreitol (DTI) (4 mM) and allowed to proceed for 12 hours at 
24° C. The reactions were stopped by freezing and lyophilization, and the 
cleavage products were analyzed by gel electrophoresis. (A, Lanes 1 to 8) 
Duplexes containing 5' end labeled d(A2T2(CT)3A5G3AG4AG3As(CT8) (B, 
Lanes 1 to 8) Duplexes containing 5' end labeled 
d(CTAG(AG)3T5C3TC4TC4T5(AG)3) (Lanes A1 and B1) Products of A specific 
cleavage reactions.l5 (Lanes A2 and B2) Controls showing intact 5' end labelled 
duplexes obtained after treatment according to the cleavage reactions in the 
absence of oligonucleotide-EDTA•Fe(II) (Lanes 3-5) Cleavage products produced 
by oligonucleotide-EDT A • Fe(II) 1 (Lanes 6-8) Cleavage products produced by 
oligonucleotide-EDTA•Fe(II) 2 (Lanes 3,6) Spermine at 10 J.LM (Lanes 4,7) 
Spermine at 100 J.LM (Lanes 5,8) Spermine at 1 mM. 
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A B 
12 3 4 56 7 8 12 3 4 56 78 
-
5' 32p 
31 
1 3'-TGGGTGGGGTGGGGTGGGT--5' 
2 3'-TGGGAGGGGAGGGGAGGGT--5' 
Figure 2.8 Histogram of DNA cleavage pattern generated by 1 derived 
from densitometry of the autoradiogram in Figure 2.7. 
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direction from the last base pair in the binding site (Figures 2.7 and 2.8). The 
efficiency of cleavage was dependent on the concentration of the polycation 
spermine with maximum cleavage occurring at 1 mM. 
The location of the cleavage sites and asymmetry of the pattern showed 
definitively that oligonucleotides 1 and 2 bound in the major groove antiparallel 
to the WC purine strand (Figure 2.8). This result ruled out strand displacement 
(D-looping) as the mode of recognition. No cleavage products corresponding to 
a parallel orientation could be detected. Triple helical complexes are known to 
be stabilized by added divalent and multivalent cations including spermine.16 
The observation that the cleavage efficiencies were dependent on the 
concentration of spermine is consistent with formation of triple helices by 1 and 
2. 
The discovery that these G-rich 19 mers bound the double helix with an 
antiparallel orientation suggested that the 27 mer oligonucleotide designed by 
Hogan to bind the c-myc promoter may also have bound in an antiparallel 
fashion. This is possible due to the pseudosymmetry of the c-myc promoter 
sequence (Figure 2.3). In fact, when orientation was explicitly determined, all G-
rich oligonucleotides designed to bind the c-myc promoter did so with an 
antiparallel orientation.6b Several subsequent reports have confirmed that 
purine-rich third strands bind antiparallel to the purine strand of duplex DNA.17 
A • AT and T • AT triplets. From the intensities of the cleavage bands in 
Figure 2.7, it appeared that 1 and 2 were binding the target site with nearly equal 
affinities. Because of the sequence design, the formation of G•GC base triplets 
dominates these binding events. However, from simple modeling of potential 
hydrogen bonding interactions, it seemed reasonable that the formation of A • AT 
and T • AT triplets could also contribute to the overall stabilities of the complexes. 
To test this hypothesis, oligonucleotide 3, of sequence 5'-
33 
T*GGGCGGGGCGGGGCGGGT-3', was prepared and assayed for binding at the 
target site along with 1 and 2. In a triple helix formed by oligonucleotide 3, three 
T • A T(1) or A • A T(2) interactions are replaced by three C • AT interactions. If the 
binding of these oligonucleotides was controlled only by the formation G•GC 
base triplets, 1, 2 and 3 would bind with equal affinities. 
The comparison of the binding of 1, 2 and 3 was made on a 648 bp 
Hindiii/ Sspl restriction fragment from the plasmid pPBAG19, which has the 19 
bp target sequence located 35 bp from the Hindiii site (Figure 2.9). Cleavage of 
the 3' end 32p labeled restriction fragment by oligonucleotidesEDTA•Fe 1-3 
could only be detected at the target site near the 3' end of the purine tract (0.1 to 
1.0 ~oligonucleotide, 0.1 mM spermine, 10 mM NaCl, pH=7.8) (Figure 2.10). 
This single locus of cleavage bands indicated that the oligonucleotides bound 
specifically at the target site in this 648 bp fragment. The absolute cleavage 
efficiencies differed depending on the identity of the base in the third strand 
opposite the three internal AT base pairs in the binding site. The relative 
cleavage efficiencies at 1 J..LM oligonucleotide concentration were 1.0 (X=T), 
0.56(X=A) and 0.13 (X=C). Therefore, for this particular sequence and under 
these conditions, the contribution to the cleavage efficiency from the formation of 
three A•AT triplets differed from that of three T•AT triplets by less than a factor 
of two. However, when C was positioned opposite three AT base pairs, the 
cleavage efficiency decreased by nearly a factor of eight. We believed that the 
differences in cleavage efficiencies was evidence for specific stabilizing 
interactions, likely hydrogen bonding, in the T•AT and A•AT triplets. 
Undoubtedly, the relative affinities of these triplets will depend on sequence 
composition. 
Models for G • GC. A • AT and T • AT triplets. Within the constraints of our 
experimental data that the third strand was antiparallel to the purine-rich we 
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1 ~TGGGTGGGGTGGGGTGGGP~ 
2 ~TGGGAGGGGAGGGGAGGGT~' 
3 ~TGGGCGGGGCGGGGCGGGT~' 
Eco Rl(396) Xba 1(439) 
I I I I 
5'-AATT CTC TCT AAAA GGGAGGGGAGGGGAGGG AAAACTCTCT-3' 
3'-GAGAGATTTT CCCTCCCC CCCCTCCCTTTTTGAGAGAGATC-5' 
Ssp I (2517) 
pPB19AG 
2702 bp 
Hind III (463) 
AlwN I (1233) 
Figure 2.9 (Top) Sequences of oligonudeotidesEDTA 1-3. (Bottom) Schematic 
diagram of pPBAG19, constructed from the ligation of a synthetic oligo-
nucleotide duplex into the EcoRI /Xbal site of pUC19. 
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Figure 2.10 (Left) Autoradiogram of an 8% polyacrylamide sequencing gel 
showing cleavage efficiency dependence on sequence composition of 
oligonucleotides 1-3. The cleavage reactions were performed on the Hindiii/Ssp 
I restriction fragment of plasmid pPBAG19 32p labelled at the 3' end. The 
reactions were carried out by combining a mixture of oligonucleotide-EDT A and 
2.5 equivalents of Fe(NH4)2(S04)2•6H20 with labelled restriction fragment[-
100 nM in bp,- 10,000 cpm] in a solution of tris acetate pH=7.8 (50 mM), NaCl 
(10 mM), spermine (100 ~M), and calf thymus DNA (100 ~Min bp) and then 
incubating at 24° C for 1 H. Cleavage reactions were initiated by the addition of 
dithiothreitol (OTT) (4 mM) and allowed to proceed for 12 H at 24° C. (Lane 1) 
Products of an A specific cleavage reaction.lS (Lane 2) Control showing intact 3' 
end labelled restriction fragment. (Lanes 3-11) Cleavage products produced by 
oligonucleotides-EDTA•Fe(II) of general sequence S'-T*G3XG4XG4XG3T-3'. 
(Lanes 3-5) X=T, (Lanes 6-8) X=A (Lanes 9-11) X=C. Concentrations of 
oligonucleotide-EDTA•Fe(II) 1-3: (Lanes 3,6,9) 1-3 at 0.1 ~M, (Lanes 4,7,10) 1-3 at 
0.5 ~M, (Lanes 5,8,11) 1-3 at 1.0 ~M. Cleavage efficiencies were quantitated 
using storage phosphorimaging plates with a Molecular Dynamics 4005 
Phosphorlmager. (Right) Ribbon model and sequence of local triple helical 
complex between oligonucleotides-EDT A • Fe(ll) and the target sequence. Circles 
represent backbone positions of cleavage. Size of circles represent extent of 
cleavage. 
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strand, models of possible hydrogen bonding patterns for base triplets place the 
phosphodiester-deoxyribose backbone in different locations in the major groove 
depending on whether the base in the third strand is in the anti or syn 
conformation (Figure 2.11) . If the third strand base were in the anti 
conformation, the likely hydrogen bonding interaction would be reverse 
3' 3' 
anti G•GC (reverse Hoogsteen) syn G•GC (Hoogsteen) 
Figure 2.11 Models for G•GC triplets. Given the third strand is antiparallel to 
the purine strand of the duplex, likely hydrogen bonding patterns depend on the 
third strand guanosine glycosidic bond conformation. 
Hoogsteen generating a structure with the phosphodiester-deoxyribose backbone 
centrally located in the major groove of the double helix. The syn conformation 
required Hoogsteen hydrogen bonding and placed the backbone in a similar 
location in the major groove as found with the pyrimidine motif. Although both 
Hoogsteen and reverse Hoogsteen models for the G•GC and T•AT triplets could 
be drawn where the third strand base was bound to the underlying base pair by 
two hydrogen bonds, only the reverse Hoogsteen model for A • AT had two 
hydrogen bonds (Figure 2.12). Also, although both syn and anti conformations 
are adopted by purine nucleosides, the anti conformation greatly dominates for 
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B 
G-GC 
Figure 2.12 (A) Models for G•Ge , A • AT and T• AT triplets within a triple helix 
motif where the third strand is antiparallel to the purine we strand and bases are 
in the anti conformation (reverse Hoogsteen triplets). (B) Triplet models where 
the third strand is antiparallel to the we purine strand and the bases are in the 
syn conformation (Hoogsteen triplets). Plus and minus indicate relative 
polarities of the strands. 
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pyrimidine nucleosides, making a syn T•AT triplet less likely.18 Hence, we 
tentatively favored the model with anti conformations and reverse Hoogsteen 
hydrogen bonding, placing the phosphodiester-deoxyribose backbone near the 
center of the major groove. This triple helix structure differed from the 
pyrimidine motif not only in triplet specificities but also in the location and 
orientation of the third strand and, therefore, constituted a second structural 
motif for triple helix formation.19 
Groove Location of EDT A • Fe. When an oligonucleotide binds in the 
major groove of double helical DNA, this groove is partitioned into two new 
grooves: one between the third strand and the purine strand of the double helix 
(groove A in Figure 2.13) and one between the third strand and the pyrimidine 
strand (groove Bin Figure 2.13). The two models for T•AT triplets (Hoogsteen 
and reverse Hoogsteen) place the third strand thymine CS methyl in one or the 
other of these two grooves. The reverse Hoogsteen T•AT places the CS methyl 
in groove A, the Hoogsteen T • AT has it in groove B. 
R 
I 
H,CJ: :r=o.... . .... o~ ~ rN· H_N.H ' ' 
A 
0 "~x)_.H'N'(N,, 
I N 
R 
reverse Hoogsteen T • AT Hoogsteen T • AT 
Figure 2.13 Triple helix formation partitions the duplex major groove into two 
new grooves (A and B). The reverse Hoogsteen T•AT triplet places the third 
strand thymine CS methyl in groove A. The Hoogsteen T•AT triplet places this 
group in groove B. 
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Moser and Dervan have shown that pyrimidine oligonucleotides 
containing thymidine EDT A at internal positions cleave only the pyrimidine 
strand of the double helix efficiently; the purine strand is protected from 
cleavage.l6 Strobel and Derva~ have also shown that pyrimidine 
oligonucleotides with T* at their 3' ends only cleave the pyrimidine strand 
efficiently.20 These observations are resultant of the right-handed helical nature 
of the triple helix and the Hoogsteen T*• AT triplet in the pyrimidine motif, 
which places the EDT A • Fe, linked to the base at the C5 position, in groove B 
between the third strand and the pyrimidine strand of the double helix. The 
purine strand is protected from cleavage by a steric blockade provided by the 
third strand sugar-phosphate backbone. 
Our preferred model for the triplets in the purine motif included a reverse 
Hoogsteen T•AT, placing the C5 methyl in groove A, between the third strand 
and the purine strand of the duplex. Given the results discussed, this model 
predicted that for a purine-rich oligonucleotide with T* at an internal position or 
at the 3' end, only the purine strand of the duplex would be cleaved efficiently; 
i.e., the pyrimidine strand would be protected. 
To determine if this prediction was correct, oligonucleotidesEDT A • Fe 4 
and 5 were prepared which differed from 1 only in the position of the 
thymidineEDT A (T*}. The cleavage generated by oligonucleotide 4, with T* at 
the center position, and oligonucleotide 5, with T* at the 3' position was analyzed 
on a 39 bp 5' end 32p labeled oligonucleotide duplex. The autoradiogram of the 
resulting cleavage products is shown in Figure 2.14. Histograms of the cleavage 
patterns for 4 and 5 are shown in Figure 2.15 along with that generated by 1. The 
cleavage sites for 4 and 5 are located at positions consistent with an antiparallel 
orientation of the third strand, with cleavage occurring at the 5' end of the 
purinetract for 5, which hasT* at its 3' end. The major cleavage sites for both 4 
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Figure 2.14 (A and B) Autoradiograms of 20% denaturing polyacrylamide gels 
used to separate cleavage products. The cleavage reactions were carried out by 
combining a mixture of oligonucleotide-EDT A (2 J!M) and Fe(II) (5 J!M) with the 
32P-labelled oligomer duplex[- 50,000 cpm] in a solution of tris-acetate pH=7.4 
(50 mM), NaCl(lO mM), spermine (1 mM), and calf thymus DNA(lOO J!M in base 
pairs) and then incubating at 24° C for 1 hour. Cleavage reactions were initiated 
by the addition of dithiothreitol (OTT) (4 mM) and allowed to proceed for 12 
hours at 24° C. The reactions were stopped by freezing and lyophilization, and 
the cleavage products were analyzed by gel electrophoresis. (A, Lanes 1 to 4) 
Duplexes containing 5' end labelled d(A2T2(CT)3A5G3AG4AG3A5(CT8) (B, 
Lanes 1 to 4) Duplexes containing 5' end labelled 
d(CTAG(AG)3T5C3TC4TC4Ts(AG)3) (Lanes A1 and B1) Products of A specific 
cleavage reactions.lS (Lanes A2 and B2) Controls showing intact 5' end labelled 
duplexes. (Lanes A3 and B3) Cleavage products produced by oligonucleotide-
EDT A • Fe( II) 5 . (Lanes A4 and B4) Cleavage products produced by 
oligonucleotide-EDT A • Fe(II) 4. 
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1 3'·TGGGTGGGGTGGGGTGGGT•·5' 
4 3'-TGGGTGGGGPGGGGTGGGT-5' 
np~AATTCTCTCTAAA~AGGGAGGGgAGGGGA~GG~AAAACTCTCT 
GAGAGA TTTT.TCCCHr T cc c n c c CLTTTTG AG A GAGA TC-5" np 
5 3'-PGGGTGGGGTGGGGTGGGT-5' 
Figure 2.15 Sequences of oligonucleotidesEDT A 1, 4 and 5, where T* indicates 
location of thymidine EDT A. Histograms of DNA cleavage patterns generated 
by 1, 4 and 5 on the 39 bp oligonucleotide duplex. 
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and 5 are on the purine strand 2-3 bases to the 5' side of the AT base pair bound 
by T*. Less efficient cleavage occurs on the pyrimidine strand. Importantly, 
cleavage on the pyrimidine strand 4-5 bases to the 5' side of the location of the 
T*• AT triplet is much less efficient for 4 and 5 than for 1. These results are 
consistent with protection of the pyrimidine stand from cleavage as would be 
predicted for a reverse Hoogsteen p· • AT triplet. 
Figure 2.16 shows the cleavage sites generated by 4 superimposed on 
ribbon models depicting a purine motif triple helix with reverse Hoogsteen or 
Hoogsteen triplets. The main sites are clustered on one face of the helix proximal 
to the groove between the third strand and the purine strand of the duplex. This 
cleavage pattern is clearly most consistent with the model with a reverse 
Hoogsteen T"·•AT triplet with the T* in the anti conformation placing the 
EDT A • Fe in this groove. If the T*• AT triplet were Hoogsteen, the main cleavage 
sites would be expected on the pyrimidine strand shifted 5' 2-3 bases from the 
position of the T*, which is not the observed result. These results are consistent 
with our preferred model for base triplets in the purine motif with third strand 
bases in the anti conformation and reverse Hoogsteen hydrogen bonding. 
NMR Studies. Subsequent to these studies, Radhakrishnan et al. 
reported an NMR spectroscopic study of an intramolecular purine motif triple 
helix containing T•AT and G•GC triplets.17c This study showed that the third 
strand bases had anti glycosidic bond conformations and the base triplet 
alignments were reverse Hoogsteen, supporting our preferred model. For 
instance, no strong NOEs were detected from the sugar Hl' to purine H8 protons 
indicating that no purines in the structure were in the syn conformation. Also, 
NOEs were observed between guanosine imino protons in the third strand and 
the guanosine H8 and H2', H2" sugar protons in the duplex, consistent with 
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3' 5' 5' 3' 5' 5' 
reverse 1-ioogstccn 1-ioogstccn 
ffil--r'~o 0 1 ·---~- . o 1 '--' r ·~H .. Y'l )-N. H •• H Y'1 
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anti T• •AT syn T• •AT 
0 
0'>-1~ 
o, Fc"'Nl 0 II 
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3' 5' 3' 3' 5' 3' 
Figure 2.16 Ribbon models of the triple helix formed by 4 with a reverse 
Hoogsteen (left) or Hoogsteen T,.• AT triplet (right). The reverse Hoogsteen 
triplet requires an anti conformation for the T,.; the Hoogsteen triplet requires a 
syn T ... Cleavage sites are designated by black circles with the size of the circle 
indicating the relative cleavage efficiency at that site. The cleavage sites are most 
consistent with the model on the left. 
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reverse Hoogsteen pairing where these protons are close in space (see Figure 
2.11). Recently, this group also published a solution structure of an 
intramolecular purine motif triple helix using a combined NMR and molecular 
dynamics approach (see Figure 2.17 for sequence).17g Figure 2.18 depicts the 
G•GC and T•AT triplets from this NMR structure, showing the reverse 
Hoogsteen hydrogen bonding interactions and anti glycosidic bond 
conformations. A view perpendicular to the helical axis looking into the groove 
between the third strand and the purine strand of the duplex is given in Figure 
2.19. Highlighted are the C5 methyl of the central thymidine in the third strand 
with the nucleotide positions cleaved most efficiently by the central T* in the 
related triple helix formed by oligonucleotideEDT A 4 . The proximity of the 
thymine methyl group and these nucleotides in this NMR structure correlates 
well with the positions cleaved by T* in the structure formed by the binding of 4 
(Figures 2.15 and 2.16). Another noteworthy feature of this structure is the 
discontinuity in the third strand backbone conformation at the 5'-TpG-3' steps 
resultant from the fact that the T•AT and G•GC triplets are not completely 
isomorphous. This deformation may indicate that alternating 5'-(ApG)n-3' 
sequences will be difficult to target by purine motif triple helix formation (Figure 
2.20). 
5'-TC C TC C TTT 
TTT~99~99~TTT 
T TTGG TG G T-3' 
Figure 2.17 Sequence of the intramolecular purine motif triple helix for which a 
solution structure was recently determined by a combined NMR and molecular 
dynamics approach.17g 
Figure 2.18 (overleaO G•GC and T•AT triplets from the Radhakrishnan and 
Patel NMR structure.17g Duplex base pairs are blue; third strand bases are red. 
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Figure 2.19 View of triple helix perpendicular to the helical axis looking into 
the groove between the third strand and the purine strand of the duplex.17g The 
duplex strands are colored blue and the third stran,d is red. The CS methyl of the 
central thymidine in the third strand is highlighted in green along with the 
nucleotide positions (yellow) cleaved most efficiently by the central 
thymidineEDTA in the related triple helix formed by 4 (Figures 2.15 and 2.16). 
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Figure 2.20 View of the third strand 5' -GTGG-3' segment showing the backbone 
conformation discontinuity resulting in poor stacking at 5'-TpG-3' step.l7g The 
phosphodiester deoxyribose backbone is colored red; the bases are blue. 
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Site-specific double strand cleavage of plasmid size DNA. 
Oligonucleotide 1 was shown to bind to its 19 bp target sequence within a 39 bp 
oligonucleotide duplex (Figure 2.7) and a 648 bp restriction fragment (Figure 
2.10). To determine if this G-rich oligonucleotide was capable of binding 
specifically to its double helical target sequence within the context of a larger 
piece of DNA, a uniquely end labeled 2.5 kbp fragment was generated from 
plasmid pPBAG19 (Figure 2.21). This fragment was obtained by digestion with 
Eco 0109 I followed by 3' end labeling and digestion with Sspl. This procedure 
generates a linear labeled fragment with the 19 bp target sequence 0.4 kb from 
the 32p labeled end. 
Oligonucleotide 1 (0.6-5 J..LM, 10 mM NaCl, 0.1 mM spermine, pH=7.8) 
induced a double strand break in this fragment generating one major cleavage 
product 0.4 kbp in length, as determined by comparison to DNA size markers 
(Figure 2.22). No other cleavage bands could be detected. Therefore, 1 bound 
sequence specifically to a single site within 2.5 kbp of double helical DNA. The 
ability of pyrimidine oligonucleotides to bind sequence specifically via triple 
helix formation has been exploited to target single sites in megabase fragments of 
DNA.25 It remains to be seen if purine-rich oligonucleotides can be similarly 
employed in very large DNA fragments. 
The effect of added ions. The stabilities of pyrimidine motif triple helices 
are greatly dependent on solution conditions including the presence of 
multivalent and/or divalent cations.l7 Early examples of the formation of triple 
helices containing pur•pur•pyr triplets also required the addition of cations, 
usually Mg+2.4,5 The formation of a triple helix by oligonucleotide 1 was shown 
to be dependent on the concentration of the multivalent cation spermine (Figure 
2.7). To determine if other cations might serve to stabilize this triple helix, the 
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Figure 2.21 (Left) Location of triple helix site in a 32p labeled 2.5 kb 
fragment from plasmid pPBAG19 (see Fig. 2.8). (Right) A schematic 
diagram and sequence of the triple helix. 
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Figure 2.22 Autoradiogram of 1% agarose gel used to separate double strand 
cleavage products. Plasmid pPBAG19 was linearized with Eco 0109 I and 3' end 
labeled with 32p. The resulting fragment was cleaved with Ssp I generating a 2.5 
kb single end labeled fragment. This labeled fragment was dissolved in buffer 
containing NaCl, TrisOAc, spermine and calf thymus DNA and was mixed with 
oligonucleotideEDT A 1, previously equilibrated with 2.5 eq. of Fe(II). After 
incubation for 1 H at 24°C, the reactions were initiated by the addition of DTT. 
The final concentrations in the reactions were as follows: 50 mM TrisOAc, 10 
mM NaCl, 100 J..I.M calf thymus DNA, and 4 mM DTT. The cleavage reactions 
were allowed to proceed for 12 H, at which time they were stopped by 
precipitation with ethanol and the cleavage products were analyzed by gel 
electrophoresis. (Lane 1) DNA size markers obtained by digestion of the end 
labeled Eco 0109 1/Ssp fragment from pPBAG19 with Sea I, AlwN I and Xba 1: 
2529 (undigested DNA), 2205, 1245 and 451 bp. (Lane 2) Control containing no 
oligonucleotide-EDT A • Fe(II); (Lanes 3-6) oligonucleotide-EDT A • Fe(II) 1; (Lane 
3) 1 at 0.62 J..I.M (Lane 4) 1 at 1.2 J..I.M (Lane 5) 1 at 2.5 J..l.M (Lane 6) 1 at 5.0 J..I.M. 
Arrow at right indicates single cleavage band. 
2.5 kb--
2.1 kb--
1.2 kb--
0.4 kb--
1 2 
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ability of 1 to cleave at its 19 bp target sequence in the Hindlll/Sspl fragment from 
pPBAG19 (see Fig. 2.10 for sequences) was tested in the absence of spermine and 
the presence of 5 mM Mg+2, Zn+2, Cd+2, Ni+2, and Co+2. 
No cleavage could be detected in the absence of added cations (Figure 
2.23, lane 3). Specific cleavage was detected in the presence of Mg+2 indicating 
that both spermine and Mg+2 serve to stabilize the triple helix formed by 1 
(Figure 2.23, lane 4). However, cleavage could not be detected in the presence of 
the other divalent ions tested. This may indicate that these metal ions are not 
capable of stabilizing the triple helix. However, since these ions have been shown 
to decrease the efficiency of the EDT A • Fe cleavage reaction, no firm conclusions 
should be drawn on their ability to stabilize the purine motif triple helix based on 
these experiments alone.22 In fact, reports have appeared in the recent literature 
on a Zn+2 stabilized triple helical structure in supercoiled plasmid DNA 
containing alternating A•AT and G•GC triplets.23 
Increasing the Na+ concentration in the presence of spermine decreases 
the equilibrium binding constant for a triple helix forming pyrimidine 
oligonucleotide.24 This result has been rationalized by invoking a competition 
between Na+ and spermine for binding sites on the triple helix with Na+ unable 
to stabilize the triple helix as efficiently. 
For guanine-rich oligonucleotides, the presence of high concentrations of 
monovalent ions could be even more detrimental to triple helix formation since 
these oligonucleotides form stable secondary structures in the presence of certain 
monovalent ions.25 These structures are stabilized by the G-quartet hydrogen 
bonding arrays which stack in a helical fashion with cations located between the 
G-quartets, K+ being more efficient than Na+ at stabilizing these structures 
(Figure 2.24). The formation of Na+or K+ stabilized G-quartet structures by G-
rich oligonucleotides potentially poses an obstacle to purine motif triple helix 
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Figure 2.23 Autoradiogram of an 8% polyacrylamide sequencing gel used to 
separate cleavage products. The cleavage reactions were performed on the 
Hindiii/Ssp I restriction fragment of plasmid pPBAG19 32p labeled at the 3' end. 
The reactions were carried out by combining a mixture of oligonucleotide-EDT A 
1 and 2.5 equivalents of Fe(NH4)2(S04)2•6H20 with labeled restriction fragment 
[- 100 nM in bp, - 30,000 cpm] in a solution of TrisOAc pH=7.4 (50 mM), NaCl 
(10 mM), MCl2, where M=Mg, Zn, Cd, Ni, or Co (5 mM) and calf thymus DNA 
(100 JlM in bp) and then incubating at 24° C for 1 H. Cleavage reactions were 
initiated by the addition of dithiothreitol (OTT) (4 mM) and allowed to proceed 
for 12 Hat 24° C. (Lane 1) Products of an A specific cleavage reaction.15 (Lane 2) 
Control showing intact 3' end labelled restriction fragment. (Lanes 3-8) Cleavage 
products produced by oligonucleotides-EDTA•Fe(II) 1 (Lane 3) No added MCl2 
(Lane 4) M=Mg (Lane 5) M=Zn (Lane 6) M=Cd (Lane 7) M=Ni (Lane 8) M=Co. 
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Figure 2.24 G quartet stabilized by a potassium ion. 
formation. 
As expected from these considerations, cleavage by 1 at its binding site in 
the 39 bp oligonucleotide duplex (see Fig. 2.8 for sequences) is inhibited by 
increasing NaCl and KCl concentration in the presence of 1 mM spermine. The 
inhibitory effect is realized at a lower concentration of KCl than NaCl, suggesting 
that an oligonucleotide secondary structure which is preferentially stabilized by 
K+ over Na+ could be important (Figures 2.25 and 2.26). 
The effect of abundant cellular ions such asK+, Na+, Mg+2, and spermine 
on the stability of the purine motif triple helix must be considered before the full 
potential of this structure for in vivo targeting of DNA sequences can be 
evaluated. These experiments provide the qualitative assessment that Mg+2 and 
spermine are stabilizing ions, whereas K+ and Na+ can be destabilizing. 
However, a thorough analysis of the effect of these ions on the kinetics and 
thermodynamics of purine motif triple helix formation has not yet been reported. 
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Figure 2.25 Autoradiogram of a 20% denaturing polyacrylamide gel used to 
separate cleavage products. The cleavage reactions were carried out by 
combining a mixture of oligonucleotide-EDT A (2J.l.M) and Fe(II) (SJ.l.M) with the 
32P-labeled 39 bp oligonucleotide duplex[- 40,000 cpm] in a solution of TrisOAc 
pH=7.8 (50 mM), spermine (1 mM), and calf thymus DNA(lOO ~in base pairs), 
NaCl or KCl at the concentration indicated below and then incubating at 24° C 
for 1 hour. Cleavage reactions were initiated by the addition of dithiothreitol 
(DTT) (4 mM) and allowed to proceed for 12 hours at 24° C. The reactions were 
stopped by freezing and lyophilization, and the cleavage products were analyzed 
by gel electrophoresis. (Lanes 1 to 11) Duplexes containing 5' end labelled 
d(A2T2(CT)3A5G3AG4AG3A5(CT8) (Lane 1) Products of an A specific cleavage 
reactions15 (Lane 2) Control showing intact 5' end labeled duplex. (Lanes 3-11) 
Cleavage products produced by oligonucleotide-EDT A • Fe( II) 1 (Lane 3) 
Cleavage products generated in the absence of a monovalent chloride (Lane 4) 
NaCl at 0.1 mM (Lane 5) NaCl at 1.0 mM (Lane 6) NaCl at 10 mM (Lane 7) NaCl 
at 100 mM (Lane 8) KCI at 0.1 mM (Lane 9) KCI at 1.0 mM (Lane 10) KCl at 10 
mM (Lane 11) KCl at 100 mM. 
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Figure 2.26 Comparison of the relative cleavage intensities for 1 in the presence 
of increasing concentrations of NaCl and KCl as determined by densitometry of 
autoradiogram in Figure 2.23. 
The effect of the 16 common base triplets at a single variable position. It 
was shown that three A•AT or three T•AT base triplets stabilized a 19 mer 
purine motif triple helix to a greater extent than three C•AT triplets.20 However, 
the effect of each of the 16 common natural base triplets on the stability of the 
purine motif triple helix was not known. For this reason, four 15 mer 
oligonucleotides were prepared. These oligonucleotides differed in sequence at a 
single position (Z), where Z = A, G, C, or T, for 6-9 respectively, and were 
equipped with thymidine-EDT A (T*) at each 3' end such that binding could be 
monitored by affinity cleaving. Because the EDT A • Fe moiety generates a 
diffusible oxidant yielding a Gaussian, sequence-independent cleavage pattern, 
the amount of cleavage observed is proportional to the fractional occupation of 
the target site by the oligonucleotide-EDTA•Fe.30 Therefore, the relative 
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stabilities of the triple helices formed by oligonucleotides 6-9 with duplexes 
differing in sequence at a single variable position (XY = AT, GC, CG, and TA) 
opposite the variant third strand base were assessed by comparing the relative 
cleavage efficiencies (Figure 2.27). 
The oligonucleotides 6-9 cleaved the target duplexes at the 5' end of the 
purine tract indicating that they bound in an orientation antiparallel to the we 
purine strand (Figure 2.28). As discussed previously, cleavage efficiencies were 
dependent on ionic conditions, particularly the concentration of spermine. Under 
conditions of high spermine concentration (0.5-1.0 mM), 6-9 cleaved the four 
duplexes equally. However, more stringent conditions could be found under 
which differences in cleavage efficiencies were detected based on a single triplet 
change (100 nM oligonucleotide-EDT A, 100 ~M spermine, 20 mM NaCl, pH 7.4). 
Under these conditions, the three combinations ZXY=AAT, TAT and GGC 
showed the most efficient cleavage (Figure 2.28, Lanes 3, 6 and 8 respectively). 
No other strong interactions could be detected. Some weak interactions were 
observed for ZXY= CAT, AGC and TCG (Figure 2.28, Lanes 5, 7, and 14 
respectively). The relative cleavage efficiencies allowed for a qualitative ranking 
of the relative stabilities of the 16 triplet combinations at a single variable 
position within this sequence context (Figure 2.29 A and B).27 
Models for the 16 common base triplets. The NMR spectroscopic studies 
of Radhakrishnan et al. indicated that the glycosidic bond conformations in a 
purine motif triple helix were anti.17c,f,g Therefore, we have considered possible 
two dimensional models for the 16 common triplets with the third strand base in 
an anti conformation. These models are shown in Figure 2.30. For each of the 
strong triplets A•AT, G•GC and T•AT, the third strand base is presumed to 
form two hydrogen bonds to the purine of the WC base pair. The three weaker 
base triplet interactions C•AT, A•GC and T•CG might be rationalized in part by 
32p 
64 
,ll'GGGZGGGGTGGGGT. 
5'- A AT T C T C T C T A A A *!A G G GX:G G G GAG G G G AJG G G A A A A ACT C T C T 
GAGAGATTTT CCC¥CCCCTCCCCTCCCTTTTTGAGAGAGATC~ 
XY =AT, GC, CG, TA 
Z=A,G,C,T 
Figure 2.27 Sequences of oligonucleotidesEDTA 6-9 are shown, where T* indicates 
the position of thymidineEDT A. The oligonucleotides differ at one position, where 
Z= A, G, C and T for 6, 7, 8, and 9 respectively. The target duplexes are indicated 
with a common variable base pair position. The box indicates the double stranded 
sequence bound by 6-9. The WC base pair (AT, GC, CG or TA) opposite the variant 
base is shaded. The arrows show sites of cleavage and heights indicate the relative 
cleavage efficiency at the indicated bases. 
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Figure 2.28 Autoradiogram of a 20% denaturing polyacrylamide gel used to 
separate affinity cleavage products. (Lanes 1-18) Duplexes containing 5' end 
labeled 5'-AATTCTCTCTAAAAAGGGXGGGGAGGGGAGGGAAAAACTC 
TCT-3'. (Lane 1) Products of an adenine specific sequencing reaction for duplex 
with X=A.15 (Lane 2) Intact 5' labeled duplex obtained after incubation under the 
conditions of the cleavage reactions in the absence of oligonucleotide-
EDTA • Fe(II). (Lanes 3-18) DNA cleavage products produced by oligonucleotide-
EDT A• Fe(ll) 1-4; 1 (Z=A) Oanes 3, 7, 11, and 15); 2 (Z=G) (lanes 4, 8, 12, and 16); 3 
(Z=C) (lanes 5, 9, 13, and 17); 4 (Z=T) (lanes 6, 10, 14, and 18). XY=AT (Lanes 3-6). 
XY=GC (Lanes 7-10). XY=CG (Lanes 11-14). XY=TA (Lanes 15-18). 
5.32p 
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Figure 2.29 (A) Bar graph of relative cleavage efficiencies determined by 
quantitative analysis using phosphor storage autoradiography of 
oligonucleotidesEDT A 6-9 on duplexes containing each of the four base pairs at 
the single variable position. Values represent the mean ±SD for two 
determinations. (B) Relative strengths of base triplets in the purine motif 
determined from relative cleavage efficiencies.(+++) >80%; (++) 80-60; (+) 60-40; 
(-) <40 % relative to the most efficient combination. 
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Figure 2.30 Models depicting the 16 possible natural base triplets for the purine 
motif triple helix. The third strand base has been positioned to maximize 
complementarity of hydrogen bonding surfaces while maintaining a backbone 
position similar to the G•GC, A•AT or T•AT triplet shown boxed. Hydrogen 
bonds are shown in triplets for which stabilizing interactions were detected; two 
for strong triplets, one for weak triplets. All bases are depicted with anti 
conformations about the glycosidic bonds.17g 
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the formation of a single hydrogen bond in each case between the third strand 
base and we base pair, while maintaining a backbone position similar to that of 
theG•GC, A•AT or T•AT triplets. 
Because the most stable base triplets form between third strand bases and 
purines of the Watson Crick GC or AT base pairs, the best potential double 
helical target sites are purine tracts. A limited number of CG base pairs may 
possibly be tolerated, if thymidine in the third strand is used (T•CG triplets). 
However, since thymidine binds tightly to the AT base pair (T•AT triplets), it is 
not a solution to specific recognition of CG. Also, no stabilizing interactions were 
detected between the third strand bases and the TA base pair. This lack of 
specific, highly stabilizing interactions at the CG or TA base pair demonstrated a 
sequence limitation to the formation of this structure. It should be emphasized 
that these triplet stabilities were determined only for the sequences shown in 
Figure 2.27, where the variable triplet is flanked by two G•GC triplets. The 
relative strengths of base triplets may vary with flanking sequence, as is 
observed in the pyrimidine motif triple helix.28 
Since the common DNA bases were shown not to form specific, stabilizing 
interactions with T A or CG base pairs, research directed toward the design of 
heterocycles which could specifically recognize TA or CG was initiated. Stilz and 
Dervan reported that 2'-deoxynebularine bound to CG and AT base pairs with 
nearly equal affinity and work is currently under way in the Dervan laboratories 
to develop nebularine analogs with increased affinity and specificity for CG base 
pairs (Figure 2.31).29 However, there have been no reported structural leads for 
the specific recognition of T A base pairs in the purine triple helix motif. 
Thermodynamic analysis of the effect of a mismatched triplet. For a 
more quantitative assessment of the effect of mismatched triplets, equilibrium 
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Figure 2.31 Models representing the Neb•CG and Neb• AT base triplets formed 
between 2'-deoxynebularine and the WC duplex base pairs CG and A T.29 
binding constants were determined for a triple helix with 15 matched triplets and 
one with a single mismatched triplet. The quantitative affinity cleavage titration 
was used for this purpose. A detailed description of this procedure has been 
published.26 Briefly, the formation of cleavage products (P cl) from the binding 
of an oligonucleotideEDTA•Fe (0) to a double helical target site (D) to form a 
triple helix (T) followed by the affinity cleavage reaction can be expressed by: 
O+D (1) 
where KT is the equilibrium binding constant for the oligonucleotide and kc1 is 
the pseudo-first order rate constant for the cleavage reaction. KT can be 
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expressed as a function of e, the fractional occupancy of the duplex target site, 
and [Oleq' the equilibrium concentration of the oligonucleotide by: 
e 1 
Kr = 1 - e [OJ <2> 
eq 
The apparent fractional occupancy of the duplex site (eapp) has been shown to be 
related to the intensity of cleavage bands Osite) at the site by the expression: 
e - I I -t (3) app - site sat 
where Isat is the intensity of the cleavage bands when e=L26 Also, with 32p 
labeled duplex DNA, very low duplex concentrations are used and the 
approximation that [O]eq=[Oltot is reasonable, since even at e=l, the 
concentration of bound 0 is negligible compared to [Oltot· Therefore, 
substituting lsitelsafl and [Oltot into equation 2 allows for the expression of KT in 
terms of Isite' lsat' and [01tot: 
KT [OJrot 
lsite = lsat 1 + Ky. (OJrot (4) 
Thus, by measuring the intensity of cleavage bands at the target site as a function 
of [Oltot' an empirical binding isotherm can be generated and from it KT can be 
determined by nonlinear least squares analysis. 
This method was used to determine the equilibrium binding constant for 
oligonucleotide 7 (where Z=G) at its 15 bp duplex target sequence located on the 
648 bp Hindiii/ Ssp! restriction fragment from the plasmid pPB19GC (where 
XY=GC) (Figure 2.32). 
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3'-"TG GGZ GGGG TGGG GT -5' 
5'- ···CTCTCTAAA AGGGXGGGGAGGGG 
3'-• •jGAGAGATTTT!TC CCYCCC CTCCCC 
648bp 
GGGAAAAACT CT C T· • ·-3' 
CCCTTTTTGAGAG\·-5' 
b32p 
Figure 2.32 Sequences of oligonucleotides 6 and 7, where Z=A and G, 
respectively, and the triple helix site present on the 648 bp Hindiii/Sspl fragments 
from pPB19GC and pPB19CG, where XY = GC and CG, respectively. 
Shown in Figure 2.33 is an autoradiogram of the polyacrylamide gel used 
to separate the cleavage products generated by 7 at this target sequence as a 
function of oligonucleotide concentration. At 100 JlM spermine, 10 mM NaCl, 
pH=7.5, the equilibrium binding constant where ZXY=GGC was determined to 
be 8.5(±0.9) x106 M-1, corresponding to a binding free energy (~GT) of 9.4(±0.1) 
kcal/mole (Figure 2.34, Table I). Similarly, the binding constant for 
oligonucleotide 6 (where Z=A) at the duplex target sequence located on the 
Hindiii/ Sspl fragment of pPB19CG (where XY=CG) was determined. Under the 
same conditions as above, the equilibrium binding constant where ZXY=ACG is 
1.6(±0.1)x106 M-1, equal to a binding free energy (~GT) of 8.4(±0.1) kcal/mole 
(Figure 2.34, Table I). This corresponds to a decrease in the binding constant by a 
factor of 5 or a destabilization of this triple helix by 1.0 kcal/mole from the 
presence of the mismatched A •CG triplet relative to the matched G •GC triplet. 
Singleton and Dervan have shown the pyrimidine motif triple helix is 
highly sensitive to mismatches, with a difference in binding free energy of 2.5-3.0 
kcal/mole when comparing matched 15 mers with 15 mers containing a single 
mismatched triplet.26 The destabilization of purine motif triple helices by base 
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Figure 2.33 Autoradiogram of an 8% denaturing polyacrylamide gel used to 
separate the cleavage products generated by 7•Fe(II) from a quantitative affinity 
cleavage experiment performed in association buffer (10 mM NaCl, 0.1 mM 
spermine tetrahydrochloride, 16 J..LM Fe(NH4)2(S04)2•6H20, 0.1 mM bp calf 
thymus DNA, 50 mM TrisOAc, pH=7.5) at 24°C on the 3' end labeled 
Hindiii/Sspl fragment from pPBGC19. Bars on the left of the autoradiogram 
indicate the 15 bp triple helix site (white bar), the bands used to measure lsite 
(dark grey bar) and the bands used to measure Iref (light grey bar). (Lane 1) 
Products of an adenine specific cleavage reaction.15 (Lane 2) Intact 3' end 
labeled fragment incubated under the reaction conditions in the absence of 
oligonucleotideEDTA•Fe (Lane 3-19) DNA affinity cleavage products produced 
by 7•Fe(II) at the concentrations indicated below: (Lane 3) 2 J..LM (Lane 4) 1 J..LM 
(Lane 5) 800 nM (Lane 6) 400 nM (Lane 7) 200 nM (Lane 8) 100 nM (Lane 9) 80 
nM (Lane 10) 40 nM (Lane 11) 20 nM (Lane 12) 10 nM (Lane 13) 8 nM (Lane 14) 4 
nM (Lane 15) 2 nM (Lane 16) 1 nM (Lane 17) 0.8 nM (Lane 18) 0.4 nM (Lane 19) 
0.2 nM. 
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3' 32p 
78 
Figure 2.34 Data from quantitative· affinity cleavage experiments involving 
oligonucleotidesEDT A 6 and 7 preequilibrated with labeled duplex DNA in 
association buffer at 24°C for 48 H followed by 4 H affinity cleavage reactions. 
The data points represent the average site specific cleavage signal intensities 
from four independent experiments. The sigmoidal curves show the titration 
binding isotherms plotted using the mean values of KT for 6 and 7 (Table I) and 
equation 4. The data points were normalized using lsat for each experiment and 
the binding curves were subsequently normalized using Isat = 1 for equation 4. 
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Table 1: Association constants at pH = 7.5 and 25°Ca 
Z•XY KT (M-1) ..1GT (kcal•mor1) 
G•GC 8.5 (±0.9) X 106 -9.4 (±0.1) 
A•CG 1.6 (±0.1) X 106 -8.4 (±0.1) 
avalues listed are mean values measured from 
four affinity cleavage titrations performed in 
association buffer (10 mM NaCl, 0.1 mM spermine, 
16 J.lM Fe(NH4)2(S04)2•6H20, 0.1 mM bp calf 
thymus DNA, 50 mM TrisOAc, pH=7.5). 
-·---
10 ... 
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triplet mismatches will be dependent on the identity of the mismatch as seen 
from the qualitative ranking of the stability of the 16 common triplets in Figure 
2.29. For one of the most destabilizing mismatches (A •CG), the energetic penalty 
was determined here to be 1.0 kcal/mole, suggesting that the purine motif triple 
helix may not be as sensitive to mismatches as is the pyrimidine motif triple 
helix. It is possible that mismatched triplets in the purine motif triple helix 
maintain a stabilizing stacking interaction, even though hydrogen bonding 
interactions are not optimal. This might result in greater stability for mismatched 
sequences. 
The effect of G • GC content on triple helix stability. Recent reports on 
the formation of purine motif triple helices involved targeting duplex sequences 
rich in GC base pairs, including the sequences discussed so far in this 
work.4,5,6b,17 Several groups have reported difficulty in forming triple helices 
comprised of mainly A • AT triplets. 3,6b, 17b In addition, T -rich oligonucleotides 
bind parallel to the purine strand at AT rich targets (pyrimidine motif triple 
helices).16 
To determine if a minimum number of G•GC triplets were necessary for 
formation of a purine motif triple helix, we designed 15 bp target sequences 
varying the GC to AT ratio. Figure 2.35 shows the sequences of these double 
helical target sites present on restriction fragments generated from cloned 
plasmids. Duplex A has eight GC and seven AT base pairs, duplex B has six GC 
and nine AT base pairs and sequence C has four GC and 11 AT base pairs. 
OligonucleotidesEDTA 10-12 were designed to bind to these duplexes by the 
formation of G•GC and T•AT triplets and their binding properties were 
determined by affinity cleaving. 
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A 3'-TTTGGGGTGGGGTTT"-5' 10 
5'-• • •CTC TCTG AA AGGGGAGGGGAA GCT CTC T• • •-3' 
t-•••GAGAGAC TTTCCCCTCCCCTTT,CGAGAGA···-5~' 
639bp 
====================================================~====~p 
B 3'-T T TTGGGTGGGTTTT"-5' 11 
5'-• .. eTC TCTG AAAAGGGAGGGAAA CT CTCT• ••-3' 
3'-• • •GAGAGAC,TTT TCCCTCCCTTT T GAGAGA• ··-5~ 
=====,===================63=9=b=p==================~===· · = ~·====~p 
c 3'-T TTT TGGTGGTTTTT"-5' 12 
5'-• • •CTCTCTG AAAAAGGAGGAAAA GCT CTC T• • •-3' 
====l:3':-•:•:•G::A:G:A:G::A:C:,T::T:T:T:T:::::::::::pC::T:T:T:T::T:C:G:A::G:A:G:A::• •:•:-5:~:::::::():• ::::
32
P 
Figure 2.35 Sequences of oligonucleotidesEDTA 10, 11 and 12 and their 
double helical target sites A, B and C present on 639 bp restriction frag-
ments from cloned plasmids. The resulting triple helices differ in G•GC 
content. 
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Figure 2.36 Autoradiogram of an 8% denaturing polyacrylamide gel used to 
separate the cleavage products generated by oligonucleotidesEDT A • Fe 10, 11 
and 12 on 3' end labeled restriction fragments containing duplex sequences A, B 
or C respectively (Figure 2.3S). The reactions were carried out by combining a 
mixture of oligonucleotide-EDT A and 2.5 equivalents of Fe(NH4)2(S04)2•6H20 
with labeled restriction fragment [- 100 nM in bp, - 30,000 cpm] in a solution of 
TrisOAc pH=7.4 (SO mM), NaCl (10 mM), spermine (1 mM) and calf thymus 
DNA (100 IJ.M in bp) and then incubating at 24° C for 1 H. Cleavage reactions 
were initiated by the addition of dithiothreitol (DTT) (4 mM) and allowed to 
proceed for 12 H at 24° C. A) Cleavage products generated by 
oligonucleotideEDTA•Fe 10 on duplex A. (Lane A1) Products of an adenine 
specific cleavage reaction.1S (Lane A2) Intact 3' end labeled fragment incubated 
under the reaction conditions in the absence of 10. (Lane A3-AS) DNA affinity 
cleavage products produced by 10• Fe(II) at the concentrations indicated below: 
(Lane A3) 0.02 IJ.M (Lane A4) 0.2 IJ.M (Lane AS) 2 IJ.M B) Cleavage products 
generated by oligonucleotideEDTA•Fe 11 on duplex B. (Lane Bl) Products of 
an adenine specific cleavage reaction. (Lane B2) Intact 3' end labeled fragment 
incubated under the reaction conditions in the absence of 11. (Lane B3-BS) DNA 
affinity cleavage products produced by 11• Fe(II) at the concentrations indicated 
below: (Lane B3) 0.02 IJ.M (Lane B4) 0.2 IJ.M (Lane BS) 2 JlM C) Cleavage 
products generated by oligonucleotideEDTA•Fe 12 on duplex C. (Lane Cl) 
Products of an adenine specific cleavage reaction. (Lane C2) Intact 3' end labeled 
fragment incubated under the reaction conditions in the absence of 12. (Lane C3-
CS) DNA affinity cleavage products produced by 12•Fe(II) at the concentrations 
indicated below: (Lane C3) 0.02 IJ.M (Lane C4) 0.2 IJ.M (Lane CS) 21J.M. 
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3'·TTTGGGGTGGGGTTT•·5' 10 
A 
5'· · • · CT C T C TgjAAAGGGGAGGGGAA ~GC T CT C T · · ·-3' 
3'-· • ·GAGAGAC T T T CCC CT C CCC T T 'LCGAGAGA · · ··5' 
B 
3'-TTTTGGG;[[Jll!T"·S~ ~1~ 
1 
5'-· .. c T c T c T gjA A A A G GG A GG G A A A AIG c T c T cT . •. -3' 
3'-· · · GAG A G ACT T T T CCC T CCC T T T T C GAG A G A ·· · -5' 
3'-TTTTTGGTGGTTTTP-5' 12 
c 
5'-·. ·C T c T c T gjA AAAAGGAGGA A AAAIGC T c T c T·. · -3' 
3'·· · ·GAGAGACT T T T T C C T CC T T TT T CGAGAGA- · · -5' 
Figure 2.37 Histograms of DNA cleavage patterns generated by 10,11 and 
12 derived from densitometry of the autoradiogram in Figure 2.36. 
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At 1 mM spermine, 10 mM NaCl, pH=7, 10 bound to duplex A antiparallel to the 
purine strand of the duplex at oligonucleotide concentrations of ~ 0.2 J.LM 
(Figures 2.36 and 2.37). Oligonucleotide 11 bound to duplex Bin an antiparallel 
orientation at oligonucleotide concentrations of ~ 2 J.LM (Figures 2.36 and 2.37). 
Interestingly, the cleavage pattern for 11 is more diffuse than that for 10, with 
cleavage extending over 12 nucleotides. Under the same conditions, no binding 
of oligonucleotide 12 could be detected on duplex C. 
These results indicated that the stability of purine motif triple helices 
could be correlated to the number of G•GC base triplets. Decreasing the number 
from eight to six destabilized the triple helix such that binding could only be 
detected at concentrations ~ 2 J.LM. In addition, the diffuse cleavage pattern 
found for this triple helix suggested that the end of the oligonucleotide 
containing the T* may not have been as tightly bound to the duplex as seen for 
the combination of 10 and duplex A. A further decrease in the number of G•GC 
base triplets to four eliminated binding. These studies indicated that for a 15 mer 
triple helix, >27% of the base triplets (four of 15) had to be G•GC to support 
purine motif triple helix formation at micromolar concentrations of 
oligonucleotide. Although the T•AT and A•AT triplets stabilize a purine motif 
triple helix when flanked on either side by G•GC triplets,27 nearest neighbor 
interactions could attenuate the stabilizing effects of these triplets, such that only 
triple helices with a minimum number of G•GC triplets will be stable. 
Purine motif triple helix formation at a purine tract from the HIV 
proviral DNA. The sequence 5'-A4GA4G6A-3' is present in the long terminal 
repeat (LTR) of the HIV proviral DNA.30 To determine if this sequence could 
support a purine motif triple helix, the plasmid pPBHIV was prepared with this 
sequence located on a Hindiii/Sspi restriction fragment. Oligonucleotides 13 and 
14 were designed to bind antiparallel to the purine strand of this duplex by the 
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3'-TTTTGTTTTGGGGGGT"-5' 13 
3'-AAAAGAAAAGGGGGGT"-5' 14 
m mmmmmm 
5'-"TTTTCTTTTCCCCCCT -3' 15 
5'-"TTTTGTTTTGGGGGGT -3' 16 
5'-• • •A T T T T T A A AAGAAAAG GG GGG T GG A AG• • ·-3' 
3'-•••TAAAA TTTTCTTTTCCCCCCT ACCTTC··--5' 
I 639bp ~ 
=======================================================~·==::np 
Figure 2.38 Sequences of oligonucleotidesEDTA 13-16 and the 16 bp purine 
tract found in the LlR of the HIV proviral DNA. This duplex sequence is 
present on the 639 bp Hindlll/Sspl fragment from pPBHIV. 
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formation of G•GC and T•AT(13) or G•GC and A•AT(14) triplets (Figure 2.38). 
In addition, oligonucleotide 15, designed to bind parallel to the purine strand by 
the formation MeC+GC and T • AT triplets, was prepared and has been 
previously shown to bind this sequence at acidic pH.31 Also, recently it was 
reported that oligonucleotides containing guanines and thymines could bind to 
purine tracts parallel to the purine strand of the duplex by the formation of 
Hoogsteen G • GC and T • AT triplets. 32 For this reason, oligonucleotide 16 was 
prepared and its binding was compared to that of 13-15. ThymidineEDTA (T*) 
was incorporated at the 5' end of each of these oligonucleotides and affinity 
cleaving was used to assess binding. 
At 1 mM spermine, 10 mM NaCl, pH=7.0, 13-15 bind the target duplex in 
the orientation designed, as evidenced by the affinity cleavage pattern generated 
on the 3' end 32p labeled Hindlll/Sspl restriction fragment from pPBHIV. Only 
weak cleavage was detected for 16 (Figures 2.39 and 2.40). The quantitative 
affinity cleavage titration was used to measure the equilibrium binding constants 
for 13 and 14 binding to this target sequence. Oligonucleotide 13 bound with a 
binding constant of 2.9(±0.9)x106 M-1, while14 bound at 2.2(±0.2)x106 M-1 (Figure 
2.41, Table II). Thus, the purine tract present in the HIV proviral DNA can 
support both pyrimidine and purine motif triple helices. When the purine motif 
triple helix is employed, oligonucleotides designed to bind by the formation of 
G•GC and T•AT or G•GC and A•AT triplets bind with nearly equal affinities. 
Since only weak cleavage could be detected for 16, the antiparallel orientation is 
preferred for oligonucleotides containing guanosine and thymine for this 
sequence, as expected from our previous work. 
The pH dependence on the recognition of GC-rich sequences through 
pyrimidine motif triple helix formation is well documented.33 The requirement 
for protonation of cytosine in the third strand to form C+GC triplets limits the 
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Figure 2.39 Autoradiogram of an 8% denaturing polyacrylamide gel used to 
separate the cleavage products generated by oligonucleotidesEDTA•Fe 13-16 on 
3' end labeled Hindiii/Sspl restriction fragment from pPBHIV. The reactions 
were carried out by combining a mixture of oligonucleotide-EDTA and 2.5 
equivalents of Fe(NH4)2(S04)2 • 6H20 with labeled restriction fragment [- 100 
nM in bp,- 20,000 cpm] in a solution of TrisOAc pH=7.4 (50 mM), NaCI (10 
mM), spermine (1 mM) and calf thymus DNA (100 J..LM in bp) and then 
incubating at 24° C for 1 H. Cleavage reactions were initiated by the addition of 
dithiothreitol (OTT) (4 mM) and allowed to proceed for 12 Hat 25°C. (Lane 1) 
Products of an adenine specific cleavage reaction.l5 (Lane 2) Intact 3' end 
labeled fragment incubated under the reaction conditions in the absence of 
oligonucleotideEDTA. (Lanes 3-6) DNA affinity cleavage products generated at 
1 J..1M oligonucleotideEDT A (Lane 3) 15 (Lane 4) 16 (Lane 5) 13 (Lane 6) 14. 
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3'-TTTTGTTTTGGGGGGP-5' 13 
5' - · . . AT T T T TIA A A A G A A A A GG G GG G AIC T GG A A G · . ·-3' 
3'-·· · T AAAAATTTTCTTTTCCCCCCTGACCTTC· · ·-5' 
~~AAAGAAAAGGGGGGT~· H 
5'-· . . AT T T T IIAA AAGAA A AGGGGGGAIC TGGAAG· . ·-3' 
3'- · · · T AAAA TTTTCTTTTCCCCCCTGACCTTC· .. -5' 
m m mmmmm 
5'-•TTTTCT TTTC CCCC CT-3' 15 
l 
5'-· . . A TT T T TIA AAAgA AAAGGGGGG~C T GG AAG·. ·-3' 
3'-· · · T AAAAATTTT T TTTCCCCCC'LGACCTTC· · ·-5' 
5'-'"TTTTGTTTTGGGGGGT-3' 16 
• + + 
5'-· . ·AT T T T IIA A A AG A A A A GGGGGGAIC T GGA AG .. --3' 
3'-·· ·TAAAA TTTTCTTTTCCCCCCTGACCTTC ·· ·-5' 
Figure 2.40 Histograms of DNA cleavage patterns generated by 13-16 on 
the Hindiii/Sspl fragment from pPBHIV as derived from densitometry of 
the autoradiogram in Fig. 2.39. 
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Figure 2.41 Data from quantitative affinity cleavage experiments involving 
oligonucleotidesEDT A 13 and 14 preequilibrated with labeled duplex DNA in 
association buffer at 24°C for 24 H followed by 6 H affinity cleavage reactions. 
The data points represent the average site specific cleavage signal intensities 
from three independent experiments. The sigmoidal curves show the titration 
binding isotherms plotted using the mean values of KT for 13 and 14 (Table II) 
and equation 4. The data points were normalized using lsat for each experiment 
and the binding curves were subsequently normalized using lsat = 1 for equation 
4. 
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- +- -Oligo 13 
---+-Oligo 14 
1 0-a 
[Oligo], M 
Table I: Association constants at pH = 7.0 and 25°Ca 
Oligo KT (M-1) ..1.GT (kcal•mor1) 
13 2.5 (±0.4) X 106 -8.7 (±0.1) 
14 2.0 (±0.7) X 106 -8.6 (±0.1) 
avalues listed are mean values measured from 
three affinity cleavage titrations performed in 
association buffer (10 mM NaCl, 1.0 mM spermine, 
0.1 mM bp calf thymus DNA, 50 mM TrisOAc, 
pH=7.0). 
1 0 ... 
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pH range (typically $ pH 7.0) within which this triple-helical structure can be 
formed. Koh and Dervan have shown that oligonucleotide 15 binds the HIV LTR 
purine tract poorly at alkaline pH due to the six contiguous MeC+GC triplets.36 
They described the design of a base analog, 3-methyl-5-amino-1H-pyrazolo[4,3-
d]pyrimidin-7-one (Pl), that can recognize GC base pairs at alkaline pH and 
allows for binding this sequence at pH~7.0 with a pyrimidine motif 
oligonucleotide. 
As expected, the binding of oligonucleotide 15 shows a strong dependence 
on pH through the range pH=7.0-7.8 with little cleavage detected at pH=7.8. 
However, the binding of the purine motif oligonucleotide 14 is relatively 
insensitive to pH from pH=6.6-7.8 (Figures 2.42 and 2.43). This is the expected 
result since no protonation is required to form the G•GC or T•AT triplets. 
Again, oligonucleotide 16 showed weak cleavage at all pH's. Thus, the formation 
of the purine motif triple helix is an alternative to the use of base analogs for 
triple helix formation at GC rich sites at pH~7.0. 
Conclusion and Prospectus. In conclusion, affinity cleaving has been used to 
characterize DNA triple helices with purine-rich third strands. These 
experiments have defined the groove location and orientation of the bound third 
strand. The common natural base triplets conferring the greatest stability have 
been identified and models for possible hydrogen bonding have been proposed. 
The energetic penalty for a single mismatched triplet in a 15 mer triple helix has 
been determined. A qualitative assessment of the effect of added ions, solution 
pH and sequence composition has also been made. 
The power of using this structure as an approach to the sequence specific 
recognition of double helical DNA was first demonstrated by Hogan and co-
workers with transcription inhibition studies.S Recently, the purine motif 
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Figure 2.42 Autoradiogram of an 8% denaturing polyacrylamide gel used to 
separate the cleavage products generated by oligonucleotidesEDTA • Fe 13, 15 
and 16 on 3' end labeled Hindiii/Sspl restriction fragment from pPBHIV as a 
function of pH. The reactions were carried out by combining a mixture of 
oligonucleotide EDT A and 2.5 equivalents of Fe(NH4)2(S04)2 • 6H20 with 
labeled restriction fragment [- 100 nM in bp, - 20,000 cpm] in a solution of 
TrisOAc at the desired pH (SO mM), NaCl (10 mM), spermine (1 mM) and calf 
thymus DNA (100 J.LM in bp) and then incubating at 24° C for 1 H. Cleavage 
reactions were initiated by the addition of dithiothreitol (OTT) (4 mM) and 
allowed to proceed for 12 H at 25°C. (Lane 1) Products of an adenine specific 
cleavage reaction.15 (Lane 2) Intact 3' end labeled fragment incubated under the 
reaction conditions in the absence of oligonucleotideEDTA. (Lanes 3, 6, 9, 12 and 
15) Cleavage products generated by 2.5 J.1M 15. (Lane 4, 7, 10, 13 and 16) Cleavage 
products generated by 2.5 J.1M 16. (Lane 5, 8, 11, 14 and 17) Cleavage products 
generated by 2.5 J..LM 13.(Lanes 3-5) pH=6.2 (Lanes 6-8) pH=6.6 (Lanes 9-11) 
pH=7.0 (Lanes 12-14) pH=7.4 (Lanes 15-17) pH=7.8. 
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Figure 2.43 Bar graphs of relative cleavage intensities for 13 and 15 as a function 
of pH as derived from densitometry of the autoradiogram in Fig. 2.42. 
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triple helix has been employed to purify GC-rich duplexes by affinity capture,34 
induce mutations at a specific site in a phage genome,35 and to bind double 
helical DNA containing all four base pairs by alternate strand triple helix 
formation.36 However, the potential of this structure has likely not yet been 
fully realized. Structural analyses using NMR spectroscopy and X-ray 
crystallography will continue to identify the atomic positions and bond 
conformations in this triple helix, providing a detailed structural basis for the 
sequence specific recognition. Thermodynamic and kinetic studies on variables 
such as oligonucleotide sequence and length, ionic conditions and temperature 
will help define the scope and limitations to triple helix formation with the 
available bases and sugar-phosphate backbones. With this information, the 
purine motif triple helix might be used as a design template for the synthesis of 
new molecules containing nonnatural bases and backbones, capable of 
recognizing a wide variety of sequences under a number of different conditions. 
Experimental Section 
General. Distilled, deionized water was used for all aqueous reactions and 
dilutions. Enzymes were purchased from Stratagene, Boehringer-Mannheim or 
New England Biolabs. Enzyme reactions were performed using the 
manufacturer's recommended protocol in the activity buffer provided. pUC19 
plasmid DNA was purchased from Sigma. Deoxynucleoside triphosphates were 
purchased from Pharmacia as 100 mM solutions. 5'-(a._32p) dATP, dGTP, dCTP 
and TTP (>3000 Ci/mmol) and 5'-(y-32P)ATP (>5000 Ci/mmol) were obtained 
from Amersham. Competent cells were purchased from Stratagene. 
Transformation, selection and maintenance of cell lines were accomplished using 
standard procedures.37 Calf thymus DNA was purchased from Pharmacia. 
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Polyacrylamide and agarose gel electrophoresis were performed using 1XTBE 
buffer. 5' and 3' end labeling was accomplished using standard procedures.37 
Cerenkov radioactivity was measured on a Beckman LS 2801 scintillation 
counter. 
Synthesis and purification of oligonucleotides. Oligonucleotides were 
prepared on an Applied Biosystems Model 380B DNA synthesizer with f3-
cyanoethyl phosphoramidites. Thymidine-EDT A (T*) was prepared as described 
and incorporated at the 3' end of oligonucleotides via the 5'-0-DMT-thymidine-
EDTA-triethylester 3'-succinyl controlled pore glass20 or via the 5'-0-DMT-
thymidine-EDTA-triethylester 3'-0-(2-cyanoethyl,N,N-diisopropyl) 
phosphoramidite.14 Deprotection ofT* oligonucleotides was carried out in 0.1 N 
NaOH at 55° C for 24 H. Oligonucleotides not containing T* were treated with 
concentrated NH40H at 55°C for 24 H. Oligonucleotides were purified either by 
polyacrylamide gel electrophoresis or by reverse phase chromatography on a 
Pharmacia FPLC system. In the gel purification technique, the deprotection 
solutions were neutralized with concentrated acetic acid and desalted on a 
Sephadex G-10 spun column followed by lyophilization. The residue resulting 
from lyophilization was resuspended in formamide loading buffer and then 
loaded onto a 20% polyacrylamide gel (19:1 monomer to bis) containing 8 M 
urea. The major UV absorbing band was cut out, crushed and the DNA was 
eluted with 200 mM NaCl, 1 mM EDTA at 37° C for 24 H. This solution was 
extensively (3-4 days) dialyzed against water. Alternatively, oligonucleotides 
were purified by using an Pharmacia FPLC ProRPC 10/10 (C2-C8) column with a 
0-40% acetonitrile gradient in 100 mM triethylammonium acetate, pH=7. 
Chromatography solvent was removed by lyophilization. The resulting residue 
was dissolved in water and lyophilized further. Oligonucleotides were 
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quantitated by determining the concentration in aqueous solution by UV 
spectroscopy at 260 nm, using the following molar extinction coefficients for each 
base: 15400 (A), 11700 (G), 7300 (C), 5700 (Me5C) 8800 (T and T*) cm-lM-1 . The 
solutions were lyophilized and the resulting oligonucleotides were stored as dry 
solids in 4-5 nmole fractions at -20° C. 
Generation of labeled 39 bp oligonucleotide duplexes. Each of the single 
stranded 43 mer oligonucleotides (SO pmoles) was 5' end labeled with T4 
polynucleotide kinase, y-32P-ATP(5000Ci/mmole, 10 mCi/mL). The labeled 
oligonucleotides were fractionated on a Sephadex G-50 spin column and 
precipitated with ethanol. This material was redissolved in 10 ~L of H20 and 
was added to its cold complementary strand (50 pmoles). The solutions were 
heated to 90° C for 3-4 minutes and allowed to cool for 1 H. The labeled 
duplexes were purified on a nondenaturing 15% polyacrylamide gel. The gel 
bands were visualized by autoradiography, and the appropriate bands were cut 
out of the gel and crushed. The DNA was eluted into 200 mM NaCl in a 37° C 
shaker for 24 H . The suspension was filtered, extracted with phenol and washed 
with diethylether. The DNA was precipitated with ethanol. Radioactivity was 
measured by scintillation counting. 
Construction of plasmid DNA. Using T4 DNA ligase, the plasmid pPB19AG 
was prepared by ligation of the duplex formed between oligonucleotides of the 
sequence 5'-AATTCTCTCTAAAAAGGGAGGGGAGGGGAGGGAAAAA 
CTCTCT-3' and 5'-CTAGAGAGAGTTTTTCCCTCCCCTCCCCTCCCTTTT 
TAGAGAG-3' into pUC19, which had been previously digested with Eco RI and 
Xba I. The plasmid pPB19GC was analogously prepared from insertion of the 
duplex formed between 5'-AATTCTCTCT AAAAAGGGGGGGGAGGGG 
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AGGGAAAAACTCTCT -3' and 5'-CT AGAGAGAGTTTTTCCCTCCCCTCCC 
CCCCCTTTTTAGAGAG-3'. The plasmid pPB19CG was prepared from insertion 
of the duplex formed between 5'-AA TTCTCTCTAAAAAGGGCGGGGAGGGG 
AGGGAAAAACTCTCT-3' and 5'-CTAGAGAGAGTTTTTCCCTCCCCTCCC 
CGCCC I 'I ITT AGAGAG-3'. The plasmid pPBSYMI containing duplex sequence 
A was prepared from insertion of the duplex formed between 5'-
AATTCTCTCTGAAAGGGGAGGGGAAAGCTCTCT -3' and 5'-CTAGAGA 
CTTTCCCCTCCCCTTTCAGAGAG-3'. Plasmids pPBSYMII (duplex sequence B) 
and pPBSYMIII (duplex sequence C) were similarly prepared with the 
appropriate synthetic oligonucleotide duplexes. The plasmid pPBHIV was 
prepared from insertion of the duplex formed between 5'-
AATT ATTTTTAAAAGAAAAGGGGGGACTGGAAG-3' and 5'-CT AGC 
TTCCAGTCCCCCCTTTTCTTTTAAAAAT-3'. Ligation products were used to 
transform Epicurian™ Coli XL 1 Blue competent cells. Colonies were selected for 
a-complementation on 25 mL Luria-Bertani medium agar plates containing 50 
~g/mL ampicillin and treated with XGAL and IPTG solutions. Large scale 
plasmid purification was performed using Qiagen purification kits according to 
the manufacturer's protocol. Plasmid DNA concentration was determined at 260 
nm using the relation 1 OD unit= 50 ~g/mL duplex DNA. 
Generation of labeled plasmid restriction fragments. Labeled restriction 
fragments from plasmids were generated as follows. Plasmid DNA (5-20 ~g) 
was linearized with Hind III or Eco0109I followed by 3' end labeling by filling in 
using the Klenow fragment of DNA polymerase I or Sequenase v. 2.0 and a...32p 
dA TP, dCTP, dTTP or dGTP. The labeled plasmid DNA was digested with Ssp I 
and the resulting fragment was isolated by nondenaturing 5% PAGE. Gel bands 
were visualized by autoradiography, cut out and eluted with 200 mM NaCl at 
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37°C for 24H. The suspension was filtered to remove polyacrylamide and the 
DNA was purified by ethanol precipitation. 
Affinity Cleaving. In a typical cleavage experiment, the labeled DNA was 
mixed with salts, buffer, spermine, and the oligonucleotide EDT A • Fe( II). This 
solution was incubated for one hour at 24° C before the cleavage reaction was 
initiated by the addition of DTT giving a final volume of 20 ~L. For reactions on 
plasmid restriction fragments, the reactions were stopped by precipitation with 
ethanol. For reactions on oligonucleotide duplexes, the reactions were stopped 
by freezing and lyophilization. Electrophoretic separation of the cleavage 
products was achieved on denaturing polyacrylamide gels. Specific reaction 
conditions are stated in the figure legends. 
Generation of autoradiograms. Agarose and 8% polyacrylamide gels were 
transferred to filter paper and dried with a BioRad Model 483 Slab drier for 1 H 
at 80° C, and the cleavage products were visualized by exposure to X-ray film 
(Kodak) at -70° C with an intensifying screen. Polyacrylamide gels of 20% were 
directly exposed to X-ray film without drying. For the generation of histograms, 
the autoradiograms were scanned by an LKB Ultroscan XL Laser Densitometer. 
Storage phosphor autoradiography. Storage phospor imaging plates (Kodak 
Storage Phosphor Screen S0230 obtained from Molecular Dynamics) were 
pressed flat against gel samples and exposed in the dark for 12-17 hours.38 A 
Molecular Dynamics 400S Phosphorlmager was used to obtain all data from the 
storage screens. The data were typically analyzed by performing volume 
integrations of the regions corresponding to intact DNA, the target site and 
reference sites using the lmageQuant v . 3.0 software running on an AST 
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Premium 386/33 computer. For the generation of histograms, signal intensity 
was quantitated along a line drawn down the lane of interest and a line graph 
was generated using lmageQuant. 
Quantitation of relative cleavage intensities by laser densitometry. For 
determination of the relative cleavage intensities generated by 
oligonucleotidesEDT A, autoradiograms of the polyacrylamide gels used to 
separate cleavage products were scanned by an LKB Ultroscan XL Laser 
Densitometer. The relative intensities were calculated by normalizing the area 
integration for the largest peak in that lane to the area integration for the largest 
peak on the gel. 
Quantitation of cleavage efficiencies by storage phosphor autoradiography. 
For analysis of the relative stabilities of the 16 common natural base triplets, 
absolute cleavage efficiencies were determined by calculating the ratio of site 
specific cleavage products generated for each triplet combination to the total 
amount of radiolabeled DNA in that lane on each gel. To account for background 
cleavage generated by unbound oligonucleotide-EDTA•Fe, the value for site 
specific cleavage was calculated by subtracting the integral value corresponding 
to a reference site in each lane from the integral value at the main cleavage site. 
Relative efficiencies were calculated by normalizing the absolute cleavage 
efficiency for each triplet combination to that of the combination yielding the 
most efficient cleavage in each experiment. 
Quantitative affinity cleavage titrations. In a typical titration, a stock solution 
was prepared containing TrisOAc at the desired pH, spermine, NaCl and calf 
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thymus DNA and the 32p labeled restriction fragment. The stock solution was 
allowed to equilibrate for 5 min at room temperature and distributed among the 
reaction tubes. OligonucleotideEDT A was dissolved in an aqueous solution of 
Fe(NH4HS04)2 • 6H20 to produce a lOX stock solution which was serially 
diluted. The lOX stock solutions of oligonucleotideEDTA were added to 
appropriate reaction tubes. The resulting solutions were allowed to equilibrate 
for 24-48 Hat 24°C. The cleavage reactions were initiated by the addition of an 
aqueous OTT solution (4 mM final concentration) and incubated for 4-6 H at 
24°C. The final concentrations of components are listed in figure legends and 
tables. The specific activity of labeled duplex was typically 10000-20000 cpm in 
each reaction tube with a concentration of less than 0.05 nM. Reactions were 
stopped by precipitation with ethanol. The precipitate was dissolved in water 
and lyophilized. The resulting pellet was dissolved in formamide TBE loading 
buffer and the resulting solutions were assayed for Cerenkov radioactivity by 
scintillation counting. The samples were heat denatured at 90°C for 4 min and 
loaded onto an 8% denaturing polyacrylamide gel. After electrophoresis in TBE 
buffer, the gel was dried on a slab gel drier and exposed to a storage phosphor 
screen at 24°C. 
Quantitative affinity cleavage titration fitting procedure. The site specific 
cleavage intensities for all oligonucleotide EDT A concentrations were calculated 
using eq. 5, where ltot and Iref represent the cleavage intensities in the site and 
reference blocks, respectively. Intensities were determined from the integration 
of storage phosphor images as described. 
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For each experiment, A. was calculated from the average of the ltot/lref ratios for 
the three lowest oligonucleotideEDTA concentrations. A theoretical binding 
curve was fit to the experimental data using the apparent maximum cleavage 
Osat) and the KT as adjustable parameters: 
(6) 
The difference between lfit and lsite for all data points was minimized using the 
nonlinear least-squares fitting procedure of KaleidaGraph (version 2.1; Abelbeck 
Software) running on a Macintosh Ilfx computer. Fits were performed without 
weighting data points. All data points were included in the fitting procedure 
unless visual inspection of the computer image revealed a flaw at either the 
target site or reference blocks. Data from experiments for which fewer than 75% 
of the data lanes were usable were discarded. KT values are reported as the mean 
of three or four titrations ± one standard deviation. 
References and Notes 
1. (a) Lipsett, M.N. Biochem. Biophys. Res. Comm. 1963, 11,224. (b) Lipsett, 
M. N. ]. Bioi. Chern. 1964, 239, 1256. 
2. Mark, C.; Thiele, D.; Nucleic Acids Res. 1978,5, 1017. 
3. Broitman, S. L.; lm, D. D.; Fresco, J. Y. Proc. Natl. Acad. Sci. USA 1988,85, 
3781. 
4. Kohwi, Y.; Kohwi-Shigematsu, T. Proc. Natl. Acad. Sci. USA 1988,85,3781. 
5. Cooney, M.; Czemuszewicz, G.; Postel, E. H.; Flint, J.; Hogan, M. E. 
Science 1988, 241,456. 
105 
6. (a) Hoogsteen, K.; Acta Cryst. 1959, 12, 822. (b) Durland, R.H.; Kessler, D.J.; 
Gwmell, S.; Duvic, M.; Pettitt, B.M.; Hogan, M.E.; Biochemistry 1991, 30, 
9246. 
7. (a) Kang, C-H.; Zhang, X.; Ratliff, R.; Mayzis, R.; Rich, A.; Nature 1992, 356, 
126. (b) Smith, F.W.; Feigon, J.; Nature 1992,356, 164. 
8. Bugg, C.E.; Thewalt, U.T.; Marsh, R.E.; Biochem. Biophys. Res. Comm. 1968, 
33,436. 
9. Pranata, J.; Wierschke, S.G.; Jorgensen, W.L.; J. Am. Chern. Soc. 1991, 113, 
2810. 
10. Williams, N. G.; Williams, L. D.; Shaw, B. R.; J. Am. Chern. Soc. 1989, 
111,7205. 
11. Klug, A.; Ladner, J.; Robertus, J.D.; J. Mol. Bioi. 1974, 89, 511. 
12. Maher, L. J.; Wold, B.; Dervan, P. B. Science 1989,245,725. 
13. Griffin, L. C.; Dervan, P. B. Science 1989, 245, 967. 
14. Dreyer, G. B.; Dervan, P. B.; Proc. Nat!. Acad. Sci. USA 1985, 82, 968. 
15. Iverson, B. L.; Dervan, P. B. Nucleic Acids Res. 1987, 15, 7823. 
16. Moser, H. E.; Dervan, P.B. Science 1987,238,645. 
17. (a) Chen, F-M.; Biochemistry 1991, 30, 4472. (b) Pilch, D.S.; Levenson, C.; 
Shafer, R.H.; Biochemistry 1991, 30, 6081. (c) Radhakrishnan, 1.; de los 
Santos, C.; Patel, D.J.; J. Mol. Bioi. 1991,221, 1403. (d) Milligan, J.F.; 
Krawczyk, S.H.; Wadwani, S.; Matteucci, M.D.; Nucleic Acids Res. 1993,21, 
327. (e) Roy, C.; Nucleic Acids Res. 1993, 21, 2845. (f) Radhakrishnan, 1.; 
Patel, D.J.; J. Am. Chern. Soc. 1993, 114, 1615. (g) Radhakrishnan, 1.; Patel, 
D.J.; Structure 1993, 1, 135. 
18. Saenger, W.; Principles of Nucleic Acid Structure (Springer-Verlag, 
NewYork, 1984). 
19. Beal, P.A.; Dervan, P.B.; Science 1991, 251, 1360. 
106 
20. Strobel, S.A.; Ph.D. Dissertation, California Institute of Technology, 
1992. 
21. Strobel, S.A.; Doucette-Stamm, L.A.; Riba, L.; Housman, D.E.; 
Dervan, P.B.; Science 1991, 254, 1639. 
22. Griffin, J.H.; Ph.D. Dissertation, California Institute of Technology, 
1989. 
23. (a) Campos, J.L.; Subirana, J.A.; J. Biomolec. Struct. Dynam. 1991,8, 793. 
(b) Beltran, R.; Martinez-Balbas, A.; Bemues, J.; Bowater, R.; Azorin, F.; 
J. Mol. Bioi. 1993, 230, 966. 
24. Maher, L.J.; Dervan, P.B.; Wold, B.J.; Biochemistry 1990,29,8820. 
25. (a) Williamson, J.R.; Raghuraman, M.K.; Cech, T.R.; Cell1989, 59,871. 
(b) Raghuraman, M .K.; Cech, T.R.; Nucleic Acids Res. 1990, 18, 4543. (c) 
Lee, J.; Nucleic Acids Res. 1990, 18, 6057. (d) Hardin, C.C.; Henderson, 
E.; Watson, T .; Prosser, J.K.; Biochemistry 1991, 30,4460. (e) Hardin, 
C.C.; Watson, T.; Corregan, M.; Bailey, C.; Biochemistry 1992, 31,833. 
26. Singleton, S.F.; Dervan, P.B.; J. Am. Chern. Soc. 1992, 114, 6956. 
27. Beal, P.A.; Dervan, P.B.; Nucleic Acids Res. 1992, 20, 2773. 
28. Kiessling, L.L.; Griffin, L.C.; Dervan, P.B.; Biochemistry 1992, 31,2829. 
29. Stilz, H.U.; Dervan, P.B.; Biochemistry 1993,32,2177. 
30. Wain-Hobson, S.; Sonigo, P.; Danos, 0.; Cole, S.; Alizon, M.; Cell1985, 
40, 9. 
31. Koh, J.S.; Dervan, P.B.; J. Am. Chern. Soc. 1992, 114, 1470. 
32. Sun, J.S.; de Bizemont, T.; Montenay,-Garestier, T.; Helene, C.; C.R. 
Acad. Sci. Paris Ser. 3 1991, 313, 585. 
33. Singleton, S.F.; Dervan, P.B.; Biochemistry 1992,31, 10995 and references 
therein. 
107 
34. Takabatake, T.; Asada, K.; Uchimura, Y.; Ohdate, M.; Kusukawa, N.; 
Nucleic Acids Res. 1992,20,5853. 
35. Havre, P.A.; Gunther, E.J.; Gasparro, F.P.; Glazer, P.M.; Proc. Natl . 
Acad. Sci. USA 1993, 90, 7879. 
36. (a) Beal, P.A.; Dervan, P.B.; ]. Am. Chern. Soc. 1992, 114, 4976. (b) 
Jayasena, S.D.; Johnston, B.H.; Nucleic Acids Res. 1992, 20, 5279. 
37. Sam brook, J .; Fritsch, E. F.; Maniatis, T.; Molecular Cloning (Cold Spring 
Harbor Laboratory, Cold Spring Harbor, NY, 1989). 
38. Johnston, R.F.; Pickett, S.C.; Barker, D.L.; Electrophoresis 1990, 11, 355. 
108 
Chapter 3 
Recognition of Double Helical DNA by Alternate 
Strand Triple Helix Formation 
109 
Introduction 
Oligonucleotide-directed triple helix formation is one of the most 
versatile among the methods for the sequence specific recognition of double 
helical DNA.l-4 This approach has been used to mediate single site specific 
cleavage of human chromosomal DNAlk as well as to block transcription in 
vitro)m,3a The ability to target a broad range of DNA sequences and the 
high stabilities of the resulting local triple helical structures makes this a 
powerful technique for binding single sites within large segments of double 
helical DNA. 
At least two classes of DNA triple helices exist which differ in the 
sequence composition of the third strand, the relative orientations and 
postitions of the three strands and the base triplet interactions.l-4 
Pyrimidine oligonucleotides bind specifically to purine tracts of double helical 
DNA in the major groove parallel to the Watson-Crick (WC) purine strand 
(pyrimidine motif). Specificity is derived from thymine (T) recognition of 
adenine-thymine base pairs (T•AT base triplets) and protonated cytosine (C+) 
recognition of guanine-cytosine base pairs (C+GC base triplets).J,2,4a-e 
Within this structural motif, guanine (G) has been shown to recognize certain 
thymine-adenine base pairs depending on the flanking sequence (G•TA base 
triplets). If An additional family of triple helical structures consists of purine-
rich oligonucleotides bound to purine tracts of double helical DNA in the 
major groove anti parallel to the we purine strand (purine motif).3 ,4f 
Sequence specificity is derived from G recogonition of GC base pairs (G•GC 
base triplets) and adenine (A) recognition of AT base pairs (A•AT base 
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triplets). Within this structural motif, T has been shown to recognize AT base 
pairs (reverse Hoogsteen T•AT base triplets). 
In these two triple helical structures, sequence specific binding occurs 
by the formation of hydrogen bonds between bases in the third strand and 
duplex base pairs, predominantly at the purines of the base pairs. 
Oligonucleotides designed to bind to purine target sequences allow for 
hydrogen bonding to the purines in consecutive base pairs without large 
distortion of the sugar phosphate backbone, maximizing stability by allowing 
stacking of bases in the third strand. Therefore, oligonucleotide directed triple 
helix formation appears to be limited to mostly purine tracts. A formidable 
challenge in the sequence specific recognition of duplex DNA by triple helix 
formation is designing oligonucleotides capable of binding mixed 
purine/pyrimidine sequences. In this work, we show that the specificities of 
two classes of DNA triple helices can be used in tandem to target mixed 
sequences of duplex DNA by alternate strand triple helix formation. 
Results and Discussion 
Alternate Strand Triple Helix Formation. Recently, it has been shown 
that pyrimidine oligonucleotide-directed triple helix formation can be 
extended to target mixed DNA sequences of the type 5'-(Pu)m(Py)n-3' and 5'-
(Py)m (Pu)n-3' by simultaneous binding to adjacent purine tracts on alternate 
strands of the WC duplex.5 To preserve the required strand orientation, 
pyrimidine oligonucleotides were linked 3' to 3' or 5' to 5'. However, since 
in the two triple helix motifs dicussed above, the third strands bind in 
opposite orientations with respect to the purine strand of the duplex. 
Therefore, it seemed plausible that an oligonucleotide consisting of 
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pyrimidines and purines with natural 3'-5' phosphodiesters might bind in 
the major groove and simultaneously recognize both strands. Base triplet 
specificities and required strand orientations would be maintained by 
alternating between structural motifs at junctions between purines and 
pyrimidines on one strand of the duplex (Figure 3.1). The base triplets of such 
a structure are shown in Figure 3.2, where thymidine and 5-
methyldeoxycytidine are bound to one strand of the duplex and 
deoxyadenosine and deoxyguanosine to the other. 
5'-(Pu)m(Py)n-3' (junction 
5'- T---Mec+ G A -3' 
'',,, '',,,, ... : ' ...... . 
5
' ,,,, ,, ..... ... . ... 
- ~ A ~ ~ ~ ~ ~ ~ ~ ~-···· --~--~--=~ c .. ,:-: --~ _....,.~ T 
3'- T=-~---c~:;...._ __ G·~-- A-:~~:~5, 
- Third Strand 
-3' } Watson-Crick 
Duplex 
- Third Strand 
Watson-Crick 
Duplex 
Figure 3.1 Models representing oligonucleotides binding in the major 
groove and simultaneously recognizing both strands of the duplex by forming 
hydrogen bonds to the purine in a WC base pair. Base triplet specificities and 
required strand orientations are maintained by alternating between triple 
helix motifs at junctions between purines and pyrimidines on one strand of 
the duplex. (Top) Triple helix formed at a 5'-(Pu)m(Py)n-3' target site. 
(Bottom) Triple helix formed at a 5'-(Py)m(Pu)n-3' target site. 
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T•AT 
0 
Figure 3.2 Models for base triplets formed when an oligonucleotide binds in 
the major groove and simultaneously recognizes both strands. All bases are 
in the anti conformation. 
orientations. 
Plus and minus indicate relative strand 
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To test this hypothesis, two duplex sequences were prepared, each 
containing 18 bp binding sites composed of two adjacent nine bp half sites on 
alternate strands capable of being bound by either pyrimidine or purine 
oligonucleotides. The sequence content is similar in both binding sites; 
however, they are opposite in polarity such that the two sequence types 5'-
(Pu)m(Py)n-3' and 5'-(Py)m(Pu)n-3' can be compared. Modeling of these two 
sequences suggested that the adjacent triple helix binding sites are in different 
relative positions in space due to the right-handed helical nature of the 
double helix. Therefore, designing triple helix forming oligonucleotides to 
bind to these two sequence types would likely require different structures at 
the junction where the transition from one motif to the other takes place. 
The 5'-(Pu)2._if.l1.2_,-3 sequence. The potential binding site, 5'-
AAGAAAAAGCTCCTCCCT-3', shown in Figure 3.3, consists of two adjacent 
nine bp purine tracts on alternate strands with a 5'-GC-3' junction. 
Oligonucleotides 1-5 were designed to bind this sequence by the formation of 
a pyrimidine motif triple helix at the 5' half site and/ or a purine motif triple 
helix at the 3' half site. Oligonucleotides 1-4 were modified with thymidine-
EDTA so that the affinity cleaving method could be used to monitor their 
binding properties. 6 
Under conditions in which very little binding is detected for the nine-
mer controls, 3 and 4, alone or in combination, both termini of the 18-mer 
oligonucleotide are bound to the duplex as indicated by cleavage generated by 
5' thymidine-EDTA in 1 and 3' thymidine-EDTA in 2 (Figure 3.4). 
Interestingly, a 16 mer oligonucleotide lacking the center two nucleotides 
cleaves the target equally as efficiently as 1 (data not shown). 
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DNase I footprinting was used to confirm the binding site size for 5, 
identical in sequence to 1 and 2, lacking thymidine-EDTA (Figure 3.5). As 
expected from the affinity cleaving results, 5 protects both strands of the 
duplex from cleavage by DNase I over a region of approximately 25 base pairs 
centered around the proposed binding site. DNase I footprint titrations with 5 
yielded an association constant Ka = 5.7± 1.4 x 106 M-1 (pH=7.0, 1.5 mM 
spermine, 5 mM NaCl, 10 mM MgCl2, 10 mM CaC12) corresponding to a 
binding free energy ~Gb = -9.2 ± 0.1 kcal/mol (Figure 3.6)? 
The reactivity of dimethylsulfate (DMS) can be used to determine the 
accessibility of the N-7 position of guanine,8 which is involved in both the 
Mec+GC and CG•G base triplets. (See Figure 3.2.) Formation of these triplets 
should protect the guanines in the duplex from methylation by DMS. In the 
presence of 10 ~M 5, all the guanines in the binding site are fully protected 
from methylation except the two at the junction, which are only marginally 
protected (Figure 3.7). 
The results of these experiments are summarized in Figure 3.8. These 
observations show that this duplex sequence can be targeted for alternate 
strand triple helix formation by linking binding domains with a 3' -5' 
phosphodiester. However, the two bases in the center of the third strand 
apparently do not stabilize the structure to a great extent and DMS 
footprinting indicates that the two base pairs at the junction are likely not 
involved in stable base triplets. 
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1 5'-*TTCTTTTTCGAGGAGGGT-3' 
2 5'- TTCTTTTTCGAGGAGGGT*-3' 
3 5'-*TTCTTTTTC -3' 
4 5'- GAGGAGGGT*-3' 
5 5'- TTCTTTTTCGAGGAGGGT-3' 
Figure 3.3 The duplex target site present on the 639 bp Hind III/Ssp I 
restriction fragment from plasmid pPBCRI containing two nine-mer purine 
tracts on alternate strands joined at a 5'-PuPy-3' junction. The double 
stranded region bound in the triple helix is boxed. The sequences of 
oligonucleotide-EDTA's 1-5 are shown, where T* indicates the position of 
thymidine-EDTA and bold type C indicates 5-methyldeoxycytidine. 
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Figure 3.4 (Left) Autoradiogram of an 8% denaturing polyacrylamide gel 
used to separate affinity cleavage products. The cleavage reactions were 
carried out by combining a mixture of oligonucleotide-EDTA (200 nM) and 
Fe(NH4)2(S04)2•6H20 (500 nM) with the 3' end 32p labeled Hind III/Ssp I 
restriction fragment from plasmid pPBCRI [ -15,000 cpm] in a solution of tris 
acetate, pH=7.0 (50 mM), spermine (1 mM), NaCl (10 mM), and calf thymus 
DNA (0.1 mM bp), and then incubating for one hour at 37° C. Concentrations 
listed are final concentrations. The reactions were initiated by the addition of 
dithiothreitol (DTT) (4 mM) and allowed to proceed for 18 hours at 37° C. The 
DNA was precipitated with ethanol and the cleavage products were analyzed 
by gel electrophoresis. (Lane 1) Products of an adenine-specific sequencing 
reaction.17 (Lane 2) Intact 3' labelled fragment obtained after incubation 
under the conditions of the cleavage reactions in the absence of 
oligonucleotide-EDTA•Fe(II). (Lanes 3-7) DNA cleavage products produced 
by oligonucleotide-EDT A • Fe(II) 1-4; 3 (lane 3); 4 (lane 4) 3+4(200 nM each) 
(lane 5); 1 (lane 6); 2 (lane 7). (Right) Sequences of triple helical complexes 
formed between oligonucleotides 1 and 2 and the S'-(Pu)9(Py)9-3' target site. 
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Figure 3.5 Autoradiogram of an 8% denaturing polyacrylamide gel used to 
separate DNase I footprinting products. The cleavage reactions were carried 
out by incubating oligonucleotide 5 with the 3' end or 5' end 32p labelled 
Hind III/Ssp I restriction fragment from plasmid pPBCRI [-20,000 cpm] in a 
solution of trisHCl, pH=7.0 (40 mM), spermine (1.5 mM), NaCl (5 mM), MgCl2 
(10 mM), CaCl2 (10 mM) for two hours at 24° C. The reactions were initiated 
by the addition of nonspecific single stranded oligonucleotide (1 J.LM) and 
DNase I (0.25 units/J.LL) and allowed to proceed for 10 minutes at 24° C. The 
reactions were stopped by the addition of calf thymus DNA (0.1 J.LM bp) and 
EDTA (50 mM). Concentrations listed are final concentrations. The DNA 
was precipitated with ethanol and the cleavage products were analyzed by gel 
electrophoresis. Odd numbered lanes contain 5' end labelled fragment; even 
numbered lanes contain 3' end labelled fragment. (Lanes 1 and 2) Intact 
labelled fragment in the absence of oligonucleotide 5 and DNase I. (Lanes 3 
and 4) Products of adenine-specific sequencing reactions.17 (Lanes 5 and 6) 
DNase I cleavage products in the absence of oligonucleotide 5. (Lanes 7 and 8) 
DNase I cleavage products in the presence of 10 J.LM oligonucleotide 5. (Lanes 
9 and 10) DNase I cleavage products in the presence of 1 J.LM oligonucleotide 
5. 
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10 J.l.M Oligo 5 - + + 
1.0 J.l.M Oligo 5 - + + 
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Figure 3.6 
1 o·7 
[Oligo 5] 
0.0001 
Data for DNase I footprint titrations involving 5. The 
enorm values were determined as described in the 
experimental section. The line indicates the best-fit 
binding isotherm from a nonlinear least squares analysis 
using eq. 2. 
121 
Figure 3.7 Autoradiogram of an 8% denaturing polyacrylamide gel used to 
separate DMS footprinting products. The reactions were carried out by 
incubating oligonucleotide 5 with the 3' end or 5' end 32p labelled Hind 
Ill/Ssp I restriction fragment from plasmid pPBCRI [ -20,000 cpm] in a 
solution of trisHCl, pH=7.0 (40 mM), spermine (1.5 mM), NaCl (5 mM), MgCl2 
(10 mM), CaCl2 (10 mM) for two hours at 24°C. The reactions were initiated by 
the addition of dimethylsulfate (DMS) (0.2% v /v) and allowed to proceed for 
90 seconds at 24°C. The reactions were stopped as described by Maxam and 
Gilbert.14 The DNA was precipitated with ethanol, redissolved in 50 J.LL 10% 
aqueous piperidine and heated at 90° C for 30 min. Concentrations listed are 
final concentrations. The solutions were lyophilized and the cleavage 
products were analyzed by gel electrophoresis. Odd numbered lanes contain 
5' end labelled fragment, even numbered lanes contain 3' end labelled 
fragment. (Lanes 1 and 2) Intact labelled fragment in the absence of 
oligonucleotide 5 and DMS. (Lanes 3 and 4) Products of adenine-specific 
sequencing reactions.17 (Lanes 5 and 6) Cleavage products generated in the 
presence of DMS in the absence of oligonucleotide 5. (Lanes 7 and 8) 
Cleavage products generated in the presence of DMS and 10 J.LM 
oligonucleotide 5. Arrows indicate guanines in the binding site not protected 
by oligonuceotide 5. 
(I) ..... ·-(J) 
X ·--(I) :r: 
(I) -·-1-o 
E-< 
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Figure 3.8 (A) Cleavage pattern generated by oligonucleotide 1. The box 
indicates the double stranded sequence bound. Positions of the arrows show 
the sites of cleavage and heights indicate extent of cleavage at that site. (B) 
Cleavage pattern generated by oligonucleotide 2. (C) DNase I footprint 
generated by oligonucleotide 5. Bases within the brackets are protected from 
cleavage by DNase I. (D) Dimethylsulfate (DMS) reactivity within the target 
site bound by oligonucleotide 5. Asterisks (*) indicate bases within the 
binding site protected from methylation by DMS. Arrows indicate bases 
within the binding site which remain reactive to DMS upon binding. 
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A) 
Oligo 1 
l 
~CTCTC~AAGAAAAAGCTCCTCCC~CTCTCT 
3'-GAGAG TTCTTTTTCGAGGAGGG GAGAGA 
B) 
Oligo2 
! 
5'-C T c T c TIA A G A A A A A G c T c c T c c c ric T c T c T 
~GAGAGATTCTTTTTCGAGGAGGG GAGAGA 
C) 
Oligo 5 (DNase I) 
~CTCTC~AAGAAAAAGCTCCTCCC~CTCTCT 
3'-GAGAG TTCTTTTTCGAGGAGGG GAGAGA 
D) 
Oligo 5 (DMS) 
* ! 
~CTCTC~AAGAAAAAGCTCCTCCC~CTCTCT 
3'-GAGAG TTCTTTTTCGAGGAGGG GAGAGA 
1 ** *** 
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_,.T_..h,_,e..____,.S_' -..... < ..... P~y...L.) 2..J P u ) ~-3 ' sequence. The target site, 5'-
TCCCTCCTCGAAAAAGAA-3', shown in Figure 3.9, is similar in sequence 
content to that shown in Figure 3.3, but opposite in polarity. Therefore, the 
two adjacent nine-mer purine tracts on alternate strands are joined at a 5'-CG-
3' junction. Oligonucleotides 6-12 were designed to bind the target by the 
formation of a purine motif triple helix at the 5' half site and/ or a pyrimidine 
motif triple helix at the 3' half site. 
In this case, when the two nine-mers are linked by a phosphodiester, 
there is no significant increase in binding affinity, as evidenced by 
comparison of the cleavage efficiency for 6 with that for 10 plus 11 (Figure 
3.10, lanes 5 and 6). However, when the oligonucleotide contains two 
thymidines between the purine and pyrimidine domains as in 8 and 9, both 
termini are bound to the duplex (Figure 3.10, lanes 8 and 9).9 One thymidine 
is not sufficient, as shown by the low cleavage efficiency of 7 (Figure 3.10, lane 
7). Oligonucleotide 12, which contains the two thymidine linker but lacks 
thymidine-EDTA was used for footprinting studies. In the presence of 10 J.!M 
12, both strands of the duplex are protected from DNase I degradation in the 
region corresponding to the putative binding site (Figure 3.11). DNase I 
footprint titrations yielded an association constant Ka= 1.5± 0.4 x 106 M-1 
(pH=7.0, 1.5 mM spermine, 5 mM NaCl, 10 mM MgCl2, 10 mM CaC12) 
corresponding to a binding free energy ~Gb = -8.4 ± 0.2 kcal/mol (Figure 3.12). 
DMS footprinting studies on this structure have shown that all the guanines 
in the binding site are protected equally from methylation. 
The intercalating footprinting reagent MPE•Fe was used to investigate 
the triplex formed by 12 at the 5'-(Py)m(Pu)n-3' target site10 (Figure 3.13). In 
addition to protection from cleavage within the binding site, a region of 
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639bp 
==~=============================~==J==32p 
~·.: 5l5l5IIISSSXSEXS8#m841El51Sl:g: 
6 5'-*TGGGAGGAGCTTTTTCTT -3' 
7 5'-*T GGGAGGAGICTTTTTCTT -3' 
8 5'-*T GGGAGGAGTTCTTTTTCTT -3' 
9 5'- TGGGAGGAGTTCTTTTTCTT*-3' 
10 5'-*T GGGAGGAG-3' 
11 5'- CTTTTTCTT*-3' 
12 5'- TGGGAGGAGTTCTTTTTCTT-3' 
Figure 3.9 The duplex target site present on the 639 bp Hind III/Ssp I 
restriction fragment from plasmid pPBCRII containing two nine-mer purine 
tracts on alternate strands joined at a 5'-PyPu-3' junction. The double 
stranded region bound in the triple helix is boxed. The sequences of 
oligonucleotideEDTA's 6-12 are shown, where T* indicates the position of 
thymidine-EDTA, bold type C indicates 5-methyldeoxycytidine and the 
underlined thymidines indicate the linker domain. 
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Figure 3.10 (Left) Autoradiogram of an 8% denaturing polyacrylamide gel 
used to separate affinity cleavage products. The cleavage reactions were 
carried out by combining a mixture of oligonucleotide-EDTA (200 nM) and 
Fe(NH4)2(S04)2 •6H20 (500 nM) with the 5' end 32p labelled Hind III/Ssp I 
restriction fragment from plasmid pPBCRII [ -15,000 cpm] in a solution of tris 
acetate, pH=7.0 (SO mM), spermine (1 mM), NaCl (10 mM), and calf thymus 
DNA (0.1 mM bp) and then incubating for one hour at 37° C. The reactions 
were initiated by the addition of dithiothreitol (DTT) (4 mM) and allowed to 
proceed for 18 hours at 37° C. Concentrations listed are final concentrations. 
The DNA was precipitated with ethanol and the cleavage products were 
analyzed by gel electrophoresis. (Lane 1) Products of an adenine-specific 
sequencing reaction.17 (Lane 2) Intact 5' labelled fragment obtained after 
incubation under the conditions of the cleavage reactions in the absence of 
oligonucleotide-EDTA•Fe(II). (Lanes 3-9) DNA cleavage products produced 
by oligonucleotide-EDTA•Fe(II) 6-11; 10 (lane 3); 11 (lane 4) 10+11 (200 nM 
each) (lane 5); 6 (lane 6); 7 (lane 7); 8 (lane 8); 9 (lane 9). (Right) Sequences of 
triple helical complexes formed between oligonucleotides 8 and 9 and the 5'-
(Py )9(Pu)9-3' target site. 
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Figure 3.11 Autoradiogram of an 8% denaturing polyacrylamide gel used to 
separate DNase I footprinting products. The cleavage reactions were carried 
out by incubating oligonucleotide 12 with the 3' end or 5' end 32p labelled 
Hind ill/Ssp I restriction fragment from plasmid pPBCRII [ -20,000 cpm] in a 
solution of trisHCl, pH=7.0 (40 mM), spermine (1.5 mM), NaCl (5 mM), MgCl2 
(10 mM), CaCl2 (10 mM) for two hours at 24°C. The reactions were initiated by 
the addition of nonspecific single stranded oligonucleotide (1 ~M) and DNase 
I (0.25 units/~L) and allowed to proceed for 10 minutes at 24°C. The reactions 
were stopped by the addition of calf thymus DNA (0.1 ~M bp) and EDTA (SO 
mM). Concentrations listed are final concentrations. The DNA was 
precipitated with ethanol and the cleavage products were analyzed by gel 
electrophoresis. Odd numbered lanes contain 5' end labelled fragment, even 
numbered lanes contain 3' end labelled fragment. (Lanes 1 and 2) Intact 
labelled fragment in the absence of oligonucleotide 12 and DNase I. (Lanes 3 
and 4) Products of adenine-specific sequencing reactions.l7 (Lanes 5 and 6) 
DNase I cleavage products in the absence of oligonucleotide 12. (Lanes 7 and 
8) DNase I cleavage products in the presence of 10 ~M oligonucleotide 12. 
(Lanes 9 and 10) DNase I cleavage products in the presence of 1 ~M 
oligonucleotide 12. 
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Figure 3.12 Data for DNase I footprint titrations involving 12. The 
E>norm values were determined as described in the 
experimental section. The line indicates the best-fit 
binding isotherm from a nonlinear least squares analysis 
using eq. 2. 
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Figure 3.13 Autoradiogram of an 8% denaturing polyacrylamide gel used to 
separate MPE • Fe footprinting products. The cleavage reactions were carried 
out by incubating oligonucleotide 12 with the 3' end or 5' end 32p labelled 
Hind III/Ssp I restriction fragment from plasmid pPBCRII [ -20,000 cpm] in a 
solution of trisHCl, pH=7.0 (40 mM), spermine (1.5 mM), NaCl (5 mM), MgCl2 
(10 mM), CaCl2 (10 mM) for two hours at 24°C. The reactions were initiated by 
the addition of MPE•Fe (5 J.iM) and DTT (4 mM) and allowed to proceed for 
five minutes at 24°C. Concentrations listed are final concentrations. The 
reactions were stopped by precipitation with ethanol and the cleavage 
products were analyzed by gel electrophoresis. Odd numbered lanes contain 
5' end labelled fragment, even numbered lanes contain 3' end labelled 
fragment. (Lanes 1 and 2) Intact labelled fragment in the absence of 
oligonucleotide 12 and MPE • Fe. (Lanes 3 and 4) Products of adenine-specific 
sequencing reactions.17 (Lanes 5 and 6) MPE•Fe cleavage products in the 
absence of oligonucleotide 12. (Lanes 7 and 8) MPE • Fe cleavage products in 
the presence of 10 JlM oligonucleotide 12. Bracket indicates bases in the 
binding site hyperreactive to MPE • Fe. 
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increased reactivity at the center of the 5'-(Py)m(Pu)n-3' site was detected. 
This single locus of hyperreactivity suggests a single high affinity 
intercalation site at the junction.11 A summary of the studies for this duplex 
target is given in Figure 3.14. These results show that targeting the 5'-
(Py)g(Pu)g-3' sequence requires at least a two nucleotide linker between the 
two binding domains. This is in contrast to the 5'-(Pu)g(Py)g-3' sequence, for 
which no linker nucleotides were necessary and in fact the two nucleotides at 
the center likely do not form base triplets. The triplex formed at the 5'-
(Py)g(Pu)g-3' site is less stable, with an association constant lower by a factor of 
four. Interestingly, a recent report on alternate strand triple helix formation 
has also shown that triple helices formed at duplex sequences of the type 5'-
(Py)m(Pu)m-3' are less stable than those at the 5'-(Pu)m(Py)n-3' sequence.5d 
In addition, the MPE • Fe reactivity pattern indicates that the base pairs near 
the site of crossover between strands provide an unusually stable binding site 
for an intercalator. In a related study, Ono et al. have proposed an ethidium 
bromide binding site at the center of the sequence 5'-(Py)g(Pu)g-3' when 
bound on alternate strands by pyrimidine oligonucleotides linked at their 5' 
ends.5c 
It is clear that the stucture and stability of the alternate strand triple 
helix depends on whether the duplex target is 5'-(Pu)m (Py)n-3' or 5'-
(Py)m(Pu)n-3'. Analysis of models of these sequences with oligonucleotides 
bound to adjacent binding sites may explain some of these observations. For 
the sequence 5'-(Pu)m(Py)n-3', the site of crossover between strands is located 
where adjacent binding sites overlap (Figure 3.15, left). Therefore, no linker 
between binding domains besides a phosphodiester is necessary for a 
successful crossover. In fact, it is likely that the two base pairs at the junction 
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Figure 3.14 (A) Cleavage pattern generated by oligonucleotide 8. The box 
indicates the double stranded sequence bound. Positions of the arrows show 
the sites of cleavage and heights indicate extent of cleavage at that site. (B) 
Cleavage pattern generated by oligonucleotide 9. (C) DNase I footprint 
generated by oligonucleotide 12. Bases within the brackets are protected from 
cleavage by DNase I. (D) MPE•Fe(II) reactivity within the target site bound by 
oligonucleotide 12. Arrows indicate positions of increased cleavage upon 
binding. Arrow heights indicate extent of cleavage at that site. Reactivity at 
the center of the 5'-(Py)m (Pu)n-3' site was detected. This single locus of 
hyperreactivity suggests a single high affinity intercalation site at the 
junction.ll 
A) 
Oligo8 
B) 
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Oligo9 
~CTCTC~TCCCTCCTCGAAAAAGA~CTCTCT 
~GAGAG AGGGAGGAGCTTTTICTTGifAGA 
C) 
Oligo 12 (DNase I) 
~CTCTC~TCCCTCCTCGAAAAAGAAfTCTCT 
~GAGAG AGGGAGGAGCTTTTTCTTGAGAGA 
D) 
Oligo 12 (MPE • Fe) 
137 
Figure 3.15 (Left) Ribbon model depicting nine-mer oligonucleotides binding 
to adjacent triple helix binding sites for the sequence 5'-(Pu)9(Py)9-3'. The 3' 
end of one binding site appears to overlap with the 5' end of the adjacent site 
in the major groove. (Right) Ribbon model depicting nine mer 
oligonucleotides binding to adjacent triple helix binding sites for the sequence 
5' -(Py)9(Pu)9-3' . No binding site overlap is apparent in the major groove. 
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are not specifically recognized in base triplets, allowing the third strand to 
maintain helical continuity as it winds along the major groove. 
For the sequence 5'-(Py)m (Pu)n-3', the adjacent binding sites do not 
overlap (Figure 3.15, right). A linker domain is necessary for successfully 
crossing the major groove in this fashion, with a minimum length 
determined here to be two nucleotide residues. Although thymidines were 
used for this purpose, further optimization of the linker structure may still be 
possible. Also, the unusual MPE•Fe reactivity at the center of this triple helix 
may indicate that the duplex undergoes conformational reorganization upon 
binding of the third strand. This might involve a local unwinding or 
bending12 at the center of this alternate strand triple helical structure, creating 
a site for intercalation. 
Multiple crossovers in the major groove. To determine if an 18 bp 
binding site comprised of three consecutive 6 bp purine tracts on alternate 
strands could support an alternate strand triple helix, two additional duplex 
sequences of the type 5'-(Pu)l(Py)m(Pu)n-3' and 5'-(Py)l(Pu)m(Py)n-3' were 
prepared. These sequences are examples of potential binding sites containing 
both the 5'-PuPy-3' and 5'-PyPu-3'junctions. For oligonucleotides to bind to 
these sequences by alternate strand triple helix formation, they must bind a 6 
bp purine tract via base triplets, cross the major groove and bind the adjacent 
purine tract, then cross back to bind to the third purine tract. 
Oligonucleotides were designed to bind to these duplex sequences according 
to the guidelines for the necessary linker structures at the junctions discussed 
in the previous sections. These oligonucleotides were comprised of three 
binding domains of six nucleotides capable of forming base triplets with a two 
thymidine linker to cross the 5'-PyPu-3' junction and a 3'-5' phosphodiester to 
cross the 5' -PuPy-3' junction. 
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The 5'-(Pu).6_~.6.1r..Y.ln-3' sequence. The potential binding site 5'-
AGAAAGCTCCCCGAAAGA-3' consists of three consecutive purine tracts on 
alternate strands with 5'-GC-3' and 5'-CG-3' junctions. Oligonucleotides 13-15 
were designed to bind this site by the formation of pyrimidine motif triple 
helices at the 5' and 3' segments and a purine motif triple helix at the center 
segment (Figure 3.16). At pH =7.0 and 25°C, no specific cleavage could be 
detected for these oligonucleotides, indicating that alternate strand triple helix 
formation at this site is much less facile than at the single crossover sequences 
discussed in the previous sections. In fact, only weak cleavage could be 
detected for 14 and 15 at acidic pH's with no apparent difference in stability. 
639bp 
==,=============================~==~j~32p 
~:: SlSlSMEf&E515555~M¥E1ilSlSlS:g: 
13 5'-*TCTTTC-3' 
14 5'-*TCTTTCGAGGGG-3' 
15 5'-*TCTTTCGAGGGGTTCTTTCT -3' 
Figure 3.16 The duplex target site present on the 639 bp Hind Ill/Ssp I 
restriction fragment from plasmid pPBCRIII containing three six-mer purine 
tracts on alternate strands joined at 5'-PuPy-3' and 5' -PyPu-3' junctions. The 
double stranded target sequence region is boxed. The sequences of 
oligonucleotide-EDTA's 13-15 are shown, where T* indicates the position of 
thymidine-EDTA, bold type C indicates 5-methyldeoxycytidine and the 
underlined thymidines indicate the linker domain. 
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The 5'-(Py)2_iflll2.~2.-3' sequence. The potential binding site 5'-
TCCCTCGAAAAGCTCCCT-3' consists of consecutive purine tracts on 
alternate strands with 5'-CG-3' and 5'-GC-3' junctions. Oligonucleotide 16 was 
designed to bind this site by the formation of purine motif triple helices at the 
5' and 3' segments and a pyrimidine motif triple helix at the center segment 
(Figure 3.17). However, very little cleavage could be detected for 16 under all 
conditions tested. 
639bp 
= -r= _= _= _= -~= _=_=_= _=_= _=_= _= _= _= _= _= _= _=_= _= _=1=.J:;::::;=:32p 
~::5X5X5]JISSSIS8*:f#-8SISSS1E§X5X5:g: 
16 5'-*TGGGAGTTCTTTTCGAGGGT-3' 
Figure 3.17 The duplex target site present on the 639 bp Hind Ill/Ssp I 
restriction fragment from plasmid pPBCRIV containing three six-mer purine 
tracts on alternate strands joined at 5'-PyPu-3' and 5' -PuPy-3' junctions. The 
double stranded target sequence region is boxed. The sequence of 
oligonucleotide-EDT A 16 is shown, where T* indicates the position of 
thymidine-EDTA, bold type C indicates 5-methyldeoxycytidine and the 
underlined thymidines indicate the linker domain. 
These unsuccessful attempts to target 18 bp sequences by alternate 
strand triple helix formation with two crossovers in the major groove point 
out a limitation to this approach to binding mixed sequences of double helical 
DNA. For successful alternate strand triple helix formation, the minimum 
length of purine tracts appears to be between 6 and 9 bp. The exact length will 
likely be dependent on sequence and structure of the linker. Optimization of 
the linker structure, in particular the design of linkers which allow for 
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continuous 1t stacking through the junctions, would likely confer greater 
stability to the alternate strand triple helices. 
Conclusions. By combining the base triplet specificities and required 
strand orientations of two distinct classes of DNA triple helices, we have 
designed oligonucleotides containing natural 3' -5' phosphodiester linkages 
which bind mixed sequences of duplex DNA by alternate strand triple helix 
formation. The duplex sequence type 5'-(Pu)m (Py)n-3' was targeted by 
linking two binding domains with a phosphodiester. However, to bind the 
duplex sequence type 5'-(Py)m(Pu)n-3', the third strand required two linker 
nucleotides at the site of crossover in the major groove. The design of 
oligonucleotides containing both pyrimidines and purines and all natural 
phosphodiester linkages capable of binding a variety of sequence types by 
crossovers in the major groove may now be possible. 
Experimental Section 
General. Distilled, deionized water was used for all aqueous reactions and 
dilutions. Enzymes were purchased from Stratagene, Boehringer-Mannheim 
or New England Biolabs. Enzyme reactions were performed using the 
manufacturer's recommended protocol in the activity buffer provided. 
pUC19 plasmid DNA was purchased from Sigma. DNase I was obtained from 
Stratagene and dilutions were made in the activity buffer recommended by 
the manufacturer. Deoxynucleoside triphosphates were purchased from 
Pharmacia as 100 mM solutions. 5'-(a.32p) dGTP (>3000 Ci/mmol) and 5'-(y-
32p)ATP (>5000 Ci/mmol) were obtained from Amersham. Competent cells 
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were purchased from Stratagene. Transformation, selection and maintenance 
of cell lines were accomplished using standard procedures.14 Calf thymus 
DNA was purchased from Pharmacia. Polyacrylamide gel electrophoresis was 
performed in 1XTBE buffer.14 5' and 3' end labelling was accomplished using 
standard procedures.14 Autoradiography was carried out using Kodak X-
Omat film. 
Synthesis and Purification of Oligonucleotides. Oligonucleotides were 
prepared on an Applied Biosystems Model 380B DNA synthesizer with b-
cyanoethyl phosphoramidites. Thymidine-EDTA was prepared as described6 
and incorporated at the 3' end of oligonucleotides via the 5'-0-DMT-
thymidine-EDTA-triethylester 3'-succinyl controlled pore glass or at the 5' end 
via the 5' -0-DMT -thymidine-EDT A-triethylester 3 '-0-(2-cyanoethyl,N ,N-
diisopropyl) phosphoramidite. Deprotection was carried out in 0.1 N NaOH 
at 55° C for 24 hours. Oligonucleotides were purified by reverse phase 
chromatography on a Pharmacia FPLC system using a ProRPC 10/10 (C2-C8) 
column with a 0-40% CH3CN gradient in 100 mM triethylammonium acetate, 
pH=7. The concentration of single-stranded oligonucleotides was determined 
at 260 nm, using the following molar extinction coefficients for each base: 
15400 (A), 11700 (G), 7300 (C), 5700 (Me5C) 8800 (T and T*) cm-1M-1. 
Construction of Plasmid DNA. Using T4 DNA ligase, the plasmid pPBCRI 
was prepared by ligation of the duplex formed between oligonucleotides of 
the sequence 5'-AATTCTCTCTAAGAAAAAGCTCCTCCCTCTCTCT-3' and 
5'-CTAGAGAGAGAGGGAGGAGCTTTTTCTTAGAGAG-3' into pUC19, 
which had been previously digested with Eco RI and Xba I. The plasmid 
pPBCRII was analogously prepared from insertion of the duplex formed 
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between 5'-AATTCTCTCTTCCCTCCTCGAAAAAGAACTCTCT-3' and 5'-
CTAGAGAGAGTTCTTTTTCGAGGAGGGAAGAGAG-3'. The plasmids 
pPBCRill and pPBCRIV were prepared from insertion of the duplexes formed 
between 5'-AATTCTCTCTAGAAAGCTCCCCGAAAGATCTCTC-3' with 5'-
CTAGAGAGAGTCTTTCGGGGAGCTTTCTAGAGAG-3' and 5'-
AATTCTCTCTTCCCTCGAAAGCTCCCTTCTCTC-3' with 5'-
CTAGAGAGAGAGGGAGCTTTTCGAGGGAAGAGAG-3', respectively. 
Ligation products were used to transform Epicurian™ Coli XL 1 Blue 
competent cells. Colonies were selected for a-complementation on 25 mL 
Luria-Bertani medium agar plates containing 50 J..l.g/mL ampicillin and 
treated with XGAL and IPTG solutions.14 Large scale plasmid purification 
was performed using Qiagen purification kits according to the manufacturer's 
protocol. Plasmid DNA concentration was determined at 260 nm using the 
relation 1 OD unit= 50 J..l.g/mL duplex DNA. 
Generation of Labeled Duplex DNA. Labelled restriction fragments from 
pPBCRI and pPBCRII were generated as follows. Plasmid DNA (20 J..l.g) was 
linearized with Hind III followed either by calf alkaline phosphatase 
treatment and 5' end labelling by T4 polynucleotide kinase with y _32p A TP or 
3' end labelling by filling in with the Klenow fragment of DNA polymerase I 
and dATP, dCTP, dTTP and a-32p dGTP. The labelled plasmid DNA was 
digested with Ssp I and the 639 bp Hindlll/Sspl restriction fragment was 
isolated by nondenaturing 5% PAGE. Gel bands were visualized by 
autoradiography, cut out and eluted with 200 mM NaCl. The suspension was 
filtered to remove polyacrylamide and the DNA was purified by ethanol 
precipitation. 
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Affinity Cleaving. In a typical cleavage experiment, the labelled DNA was 
mixed with salts, buffer, spermine, and the oligonucleotide EDTA•Fe(II) . 
This solution was incubated for one hour at 37° C before the cleavage reaction 
was initiated by the addition of DTI giving a final volume of 20 J.LL. Cleavage 
reactions were allowed to proceed for 18 hours at 37° C. The reactions were 
stopped by precipitation with ethanol. Electrophoretic separation of the 
cleavage products was achieved on a denaturing 8% polyacrylamide gel. The 
gel was transferred to filter paper and dried for one hour at 80° C . Cleavage 
products were visualized by autoradiography and the relative amounts of 
cleavage products were analyzed by storage phosphor autoradiography. 
Specific reaction conditions are stated in the figure legends. 
Storage Phosphor Autoradiography. Storage phospor imaging plates (Kodak 
Storage Phosphor Screen S0230 obtained from Molecular Dynamics) were 
pressed flat against gel samples and exposed in the dark for 12-17 hours.15 A 
Molecular Dynamics 400S Phosphorimager was used to obtain all data from 
the storage screens. The data were analyzed by performing volume 
integrations of the regions corresponding to intact DNA, the target site and 
reference sites using the ImageQuant v . 3.0 software running on an AST 
Premium 386/33 computer. 
DNase I Footprinting. In a typical DNase I footprinting experiment, the 
labelled DNA was mixed with salts, buffer, spermine, and the 
oligonucleotide. This solution was incubated for two hours at 24° C before 
the addition of nonspecific oligonucleotide and DNase I giving a final 
volume of 20 J.LL. The nonspecific single stranded oligonucleotide 5'-
ATCTGATGAGGTGCTGAATAGGACC -3' was included in all DNase I 
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footprinting reactions to maintain uniform DNase I activity in the presence 
and absence of triple helix forming oligonucleotides. For footprint titrations, 
the incubation period was extended to 24 hours to insure samples containing 
low concentrations of triple helix forming oligonucleotides had reached 
equilibrium. The DNase I reactions were allowed to proceed for 10 minutes at 
24°C and stopped by the addition of calf thymus DNA and EDTA, followed by 
precipitation with ethanol. Electrophoretic separation of the cleavage 
products was achieved on an 8% polyacrylamide gel. The gel was transferred 
to filter paper and dried for one hour at 80° C. DNase I cleavage products 
were visualized by autoradiography and analyzed by storage phosphor 
autoradiography. Specific reaction conditions are stated in the figure legends. 
For DNase footprint titrations, the apparent site saturation was determined as 
described by Ackers7 using the following equation: 
e =l-app 
Itot/lref 
ltot0 /lref> 
(1) 
where ltot and Iref are the integrated volumes at the target site and reference 
sites, respectively, and ltot0 and Iref0 correspond to those values for a control 
lane with no oligonucleotide added. The data were fit to a binding isotherm 
by minimizing the difference between E>app and E>fit: 
where [L] corresponds to the total oligonucleotide concentration, Ka 
corresponds to the apparent association constant, and E>min and E>max 
represent the experimentally determined site saturation values when the site 
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is unoccupied or saturated, respectively. Data were normalized using the 
following equation: 
(3) 
Curves were fitted to the experimental data using KaleidaGraph v. 2.1 
(Abelbeck Software) running on a Macintosh Ilfx personal computer, with the 
upper and lower end points of the curve and Ka as adjustable parameters. 
The association constants are reported in the text as the mean± one standard 
deviation for three experiments. 
Dimethylsulfate Footprinting. In a typical OMS footprinting experiment, the 
labelled DNA was mixed with salts, buffer, spermine, and the 
oligonucleotide. This solution was incubated for two hours at 24° C before 
the addition dimethylsulfate giving a final volume of 20 ~L. The reactions 
were allowed to proceed for 90 seconds at 24°C, stopped as described by Maxam 
and Gilbert, and the DNA was precipitated with ethanoi.16 The reaction 
products were redissolved in 10% aqueous piperidine and heated at 90°C for 
30 minutes. The solutions were lyophilized to dryness. Electrophoretic 
separation of the cleavage products was achieved on an 8% polyacrylamide 
gel. The gel was transferred to filter paper and dried for one hour at 80° C. 
Cleavage products were visualized by autoradiography and analyzed by 
storage phosphor autoradiography. Specific reaction conditions are stated in 
the figure legends. 
MPE • Fe (II) Footprinting. In a typical MPE • Fe(II) footprinting experiment, the 
labelled DNA was mixed with salts, buffer, spermine, and the 
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oligonucleotide. This solution was incubated for two hours at 24°C before the 
addition of MPE•Fe(II) and DTT to a final volume of 20 ~L. The reactions 
were allowed to proceed for five minutes at 24° C and stopped by precipitation 
with ethanol. Electrophoretic separation of the cleavage products was 
achieved on an 8% polyacrylamide gel. The gel was transferred to filter paper 
and dried for one hour at 80° C . Cleavage products were visualized by 
autoradiography and analyzed by storage phosphor autoradiography. Specific 
reaction conditions are stated in the figure legends. 
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Chapter 4 
Investigations Directed Toward the Sequence-
specific Transesterifica tion of RNA 
152 
Introduction 
Reagents capable of the sequence specific cleavage of nucleic acids are 
indispensible research tools for molecular biology and show promise as 
theraputics in the fight against disease.1,2 Therefore, the design and synthesis 
of new sequence specific cleaving molecules is currently an active area of 
research in academics and industry.3 The generation of these reagents 
requires the combination of the two functions of sequence specific recognition 
and cleavage of the sugar-phosphodiester backbone. One approach is to 
synthesize DNA/RNA binding molecules with reactive functionalities 
capable of oxidative degradation of the (deoxy)ribose, electrophilic 
modification of the bases or hydrolysis of the phosphodiester backbone 
(Figure 4.1). Examples of designed molecules with the ability to cleave DNA 
Electrophilic modification of base 
I o 
~N?NH NJl ~ 
RO--yoy N NH2 
H NH2 
\ 'N 0 OH NJC 
-o--f=O ~ I ) 
Phosphodiester---- 0H----N  
hydrolysis 
Oxidative degradation of 
R'O OH sugar 
Figure 4.1 Reactions of nucleic acids which can lead to strand scission 
at specific sites through oxidative degradation of the deoxyribose are 
plentiful.4 These molecules are believed to generate lesions in the strand by a 
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reaction cascade initiated through hydrogen atom abstraction from the 
deoxyribose, often by a diffusible oxidant capable of reacting at several 
nucleotide positions. More specific cleavage has been achieved by tethering 
electrophilic functional groups to sequence specific DNA binding molecules, 
which react at nucleophilic sites on the purine bases leading to alkaline labile 
positions in the DNA strand.3a-f 
The paucity of reports on designed molecules capable of specific 
scission of the nucleic acid strand through hydrolysis of the phosphodiester 
suggests this approach may be more challenging.S However, hydrolytic 
cleavage has several advantages over electrophilic modification or oxidative 
cleavage. Hydrolysis is not limited to specific base positions, generates 
termini which are compatible with subsequent enzymatic manipulation and 
cleaves the phosphodiester backbone without the use of highly reactive 
oxidants or subsequent base workup. Therefore, a major reseach goal is the 
development of reagents which promote sequence specific hydrolytic cleavage 
of nucleic acids. 
The stability of the phosphodiesters in nucleic acids poses a significant 
obstacle to the development of these reagents. For instance, the 
phosphodiester bond in RNA has been estimated to have a t112 for hydrolysis 
near 2000 years at 25°C, pH=7.6 However, this obstacle is overcome by both 
protein enzymes and ribozymes, which carry out hydrolytic cleavage of RNA 
in minutes at 37°C (rate accelerations of 109-Jo12).7 This high level of 
catalysis is usually achieved at an active site containing specifically bound 
metal ions. The role of the metal ion is not always known in detail, and 
several mechanisms by which metal ions might facilitate these reactions have 
been proposed.8 These include a) electrophilic activation of the phosphorus, 
b) charge neutralization of the phosphate, c) delivery of a nucleophile 
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(coordinated -oH) at physiological pH, d) delivery of a general acid 
(coordinated H20) or general base (coordinated -oH), at physiological pH, e) 
orientation of reacting groups through metal ion coordination, and f) 
activation of the phosphodiester in a strained chelate. 
Certain metal ions and metal complexes have been shown to promote 
cleavage of RNA phophodiesters through a transesterification reaction 
resulting in the formation of a 2',3'cyclic phosphodiester (Figure 4.2).9 The 
0 
t~NH NJl ~ 
Royoy N NH2 
H NH2 0 OH NJC \ 'N 
-o--f=O ~ I J 
O~N N 
R'O OH R'O OH 
Figure 4.2 Some metal ions can promote the transesterification of RNA 
leading to a product with a 2',3' cyclic phosphodiester. 
lanthanide(III) ions are particularly competent, with thulium(III) accelerating 
the transesterification of ApA by a factor of 107 over background at 30°C, 
pH=8.9e The reactivities of these ions are maintained in complexes with the 
hexadentate Schiff-base macrocyclic ligand (L), which are relatively inert to 
metal release (Figure 4.3) .9f Interestingly, the RNA transesterifcation 
reactions promoted by these ions and complexes are much more facile with 
phosphodiesters in extrahelical nucleotides (i.e., phosphodiesters in single 
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stranded regions, loops and bulges) than for phosphodiesters in helical 
secondary structures.l 0 It is believed that this is a result of the 
conformational rigidity of the helical regions which prevent the 
phosphodiester and 2' hydroxyl from adopting the proper relative orientation 
for reaction. 
The ability of these complexes to promote RNA transesterifcation, their 
stability toward metal release and the possibility of attachment to RNA 
binding molecules through functionalization of the macrocycle lead us to 
Figure 4.3 Hexadentate Schiff-base macrocyclic lanthanide(III) complex 
investigate methods for their attachment to oligonucleotides and to assess the 
reactivities of the resulting compounds. It seemed reasonable that the 
recognition properties of oligonucleotides and the reactivity of these metal 
complexes might be combined to generate reagents capable of sequence 
specific recognition of RNA through specific hydrogen bonding and 
induction of localized strand breaks by lanthanide(III) complex promoted 
transesterification reactions. 
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Results and Discussion 
Preparation of modified oligdeoxyribonucleotides. Disulfide bond 
formation was chosen as a mild and specific method for the covalent 
attachment of the lanthanide(III) complex to oligonucleotides. For this 
purpose, oligonucleotides containing free thiol groups and a metal complex 
with an activated disulfide were prepared. For the generation of the suitably 
functionalized metal complex, cerium(III) complex (2) was prepared via the 
eight step synthesis of Carreira and Dervan.ll Further elaboration of the 
primary amine by acylation with 3-(2-pyridyldithio)propionic acid N-
hydroxysuccinimide ester gave complex (3) functionalized through an 11 
atom linker to an activated disulfide (Scheme I). Thiol containing 
oligodeoxyribonucleotides were generated by automated synthesis using 
H 
I 
o""yN~NR 
~~ 
eN......._ I.a ...... ) /e"'-. Ny;r' I N" 
lh 
2 R=H 
a[3 R=~s'5~ 
r.;~ 
Scheme I a) 3-(2-pyridyldithio)propionic acid N-hydroxysuccinimide ester, 
TEAA, CH3CN. 
standard solid phase methods with a protected thiol phosphoramidite used in 
the last coupling step. The synthesis of this phosphoramidite is shown in 
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Scheme II. 5-Trityl-3-mercaptopropanol (4), prepared in a single step from 3-
bromopropanol and tritylmercaptan, was activated by reaction with 2-
cyanoethyl N,N-diisopropylphosphoramidous chloride giving the 5-trityl 
protected phosphoramidite (5) in 85% yield. Oligonucleotides prepared with 
this phosphoramidite were deprotected at the base and phosphodiester 
a 
5~0, 
P-O 
I ~ 
T)- CN 
4 5 
Scheme II a) 2-cyanoethyl N,N-diisopropylphosphoramidous chloride, 
Hunig's base, DCM. 
positions with concentrated NH40H and purified by reverse phase 
chromatography. Removal of the thiol protecting group was achieved by 
treatment with silver nitrate followed by removal of excess silver by 
complexation with dithiothreitol (OTT), as described by Connolly and 
Rider.12 
Disulfide exchange reactions between thiol containing 
oligodeoxyribonucleotides and (3) were followed by reverse phase HPLC 
(Figures 4.4 and 4.5). For instance, 5-trityl protected oligonucleotide (6) was 
treated with silver nitrate followed by OTT generating a new oligonucleotide 
(7) with a retention time shorter by 11.6 minutes (Figure 4.5, A and B). This 
oligonucleotide was treated with 3.3 equivalents of (3) (Figure 4.5, C) in an 
aqueous solution of triethylammonium acetate, pH=7.0. The HPLC 
chromatogram of the reaction mixture after one hour contained three peaks, 
corresponding to the pyridine-2-thione byproduct of the disulfide 
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Figure 4.4 Generation of modified oligodeoxyribonucletides via disulfide 
exchange reactions between thiol containing oligonucleotides and (3). 
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Figure 4.5 HPLC analysis of reaction components in the generation of 
modified oligodeoxyribonucleotide (8). HPLC analyses were carried out as 
described in the experimental section. A) S-Trityl oligodeoxyribonucleotide 
(6) B) Thiol containing oligodeoxyribonucleotide (7) obtained by treatment of 
(6) with AgN03 followed by DTT C) Activated cerium(III) complex (3) D) 
Products of the reaction of (7) and (3) after lH at room temperature E) 
Coinjection of (7) with the (7) + (3) reaction products F) Modified oligodeoxy-
ribonudeotide (8) purified by ethanol precipitation. 
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exchange reaction, a new oligonucleotide, and unreacted (3) (Peaks a, band c 
respectively in Figure 4.5, D). Coinjection of this reaction mixture with (7) 
shows conclusively that a new oligonucleotide was formed in the reaction 
with a retention time 2.5 min. longer than (7) (Figure 4.5, E, peaks a and b). 
Precipitation from the reaction mixture with ethanol and sodium acetate 
gave (8) as a single compound by HPLC analysis. 
Analysis of the transesterification potential of modified 
oligonucleotides. The ability of the 19 nt oligodeoxyribonucleotide (8) to 
promote transesterification reactions in a 5'-3 2 P labeled 37 nt 
oligoribonucleotide was assessed by gel electrophoresis. Formation of a 
hybrid duplex between this oligoribonucleotide and (8) would place a region 
of single stranded RNA near the 5' end of (8) (Figure 4.6). However, under a 
variety of salt conditions and temperatures, no reproducible cleavage of the 
oligoribonucleotide above background could be detected (Figure 4.7). 
5'-R-AAAGAAAAGACCTCGTCCG-3' 
3'-cagcgagguguuuucuuuuuucuuuucuggagcaggc-s· 32p 
H 0 
~~~ _.s~o. ,o~ =R 
~ H s a·•,o 
(~' 1 .., --- ~ /ce ..........._ ~ 
N)y' I N" 
I ~ 
Figure 4.6 Sequences of modified oligodeoxyribonucleotide (8) and its RNA 
target (lower case letters indicates RNA). 
To determine if different sequences or configurations of RNA and 
modified DNA might lead to specific transesterification, the modified 
oligodeoxyribonucleotides and target oligoribonucleotides in Figure 4.8 were 
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Figure 4.7 Autoradiogram of the 20% denaturing polyacrylamide gel used to 
analyze transesterification reactions. The reactions were carried out by 
combining 32p labeled RNA (50 nM, 2x106 cpm) in a solution of 50 mM 
Hepes, pH=7.0 and 10 mM NaCl with either cerium(III) complex (1) (lanes 2-7) 
or modified oligodeoxyribonucleotide (8) (lanes 8-13) in a total volume of 200 
~L and incubating at 37°C. At various times, 20 ~L of the reaction mixture 
was removed and the reaction was stopped by ethanol precipitation and the 
products were analyzed by gel electrophoresis. (Lane 1) Untreated labeled 37 
nt oligoribonucleotide (Lanes 2-7) Complex (1) at 0.5 ~M (Lanes 8-13) Modified 
oligodeoxyribonucleotide (8) at 0.5 ~M (Lanes 2 and 8) 0 hours (Lanes 3 and 9) 
1 hour (Lanes 4 and 10) 2 hours (Lanes 5 and 11) 4 hours (Lanes 6 and 12) 8 
hours (Lanes 7 and 13) 16 hours (Lane 14) Products of a reaction with the G 
specific ribonuclease T1. 
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Figure 4.8 Double and triple helical structures prepared to assess the 
transesterfication potential of modified oligodeoxyribonucleotides. (RNA is 
designated by lower case letters.) 
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prepared. These oligonucleotides were designed to form hybrid secondary 
structures placing reactive nucleotide positions in the RNA near the 
modified 5' ends of the oligodeoxyribonucleotides. The hybrid duplex in 
Figure 4.8 A contains a different duplex sequence than that discussed in the 
previous section. The triple helix shown in Figure 4.8 B was designed to place 
the attached metal complex near loop nucleotide positions in the RNA. The 
triple helix in Figure 4.8 C was designed to place the metal complex near 
bulged RNA nucleotides. Conjugation of the macrocyclic cerium(ITI) complex 
to the oligodeoxyribonucleotides was carried out via disulfide exchange 
reactions with thiol containing oligonucleotides and (3) as described in the 
previous section. However, upon incubation under a variety of conditions, 
no reproducible cleavage above background could be detected for these 
structures, even though gel shift analyses and footprinting experiments 
showed that the structures in Figure 4.8 A and B were forming. 
The lack of detailed mechanistic studies on lanthanide ion/ complex 
mediated transesterification reactions made the interpretation of these 
unexpected negative results difficult. For instance, the specific role of the 
metal ion in catalysis is not known. However, it has been proposed that these 
ions facilitate reaction by electrophilic catalysis through specific coordination 
to the phophodiester oxygens.9d This mechanism is supported by an X-ray 
structural analysis of crystals containing complex (1) bound to 
dimethylphosphate, which showed each of the nonbridging oxygens of 
dimethylphosphate coordinated to a metal complex.l3 Given this 
information, it seemed plausible that no transesterification was seen because 
the metal complex was intramolecularly coordinated to DNA 
phosphodiesters in the modified oligodeoxyribonucleotide, which might lock 
the complex in a nonproductive binding mode. 
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This hypothesis suggested that a self cleavage reaction might be 
detected if the metal complex were covalently attached to a labeled 
oligoribonucleotide and intramolecular coordination were to occur. To test 
this idea and to determine if the conjugation procedure could be used to 
generate modified RNA's, oligoribonucleotides (9-12) were prepared. 
Oligoribonucleotide (10) was prepared by automated RNA synthesis using 
standard procedures with phosphoramidite (5) employed in the last coupling 
step. Deprotection of the RNA was carried out in ammonia saturated 
methanol followed by tetrabutylammonium fluoride in tetrahydrofuran. 
The 5' S-trityl-oligoribonucleotide (10) was purified by polyacrylamide gel 
electrophoresis. (Oligoribonucleotide (9) was prepared as a size marker for 
electrophoresis analyses) . Oligonucleotides (9) and (10) were 3' end 32p 
labeled by established procedures.14 
Disulfide exchange reactions between thiol containing 32p labeled 
oligoribonucleotides and (3) were followed by 20% polyacrylamide gel 
electrophoresis (Figure 4.9). S-Trityl protected oligoribonucleotide (10) was 
treated with silver nitrate followed by dithiothreitol (DTT) generating a single 
new oligonucleotide (11) which migrated through the gel more rapidly, 
consistent with a lower molecular weight (Figure 4.9, lanes 2 and 3). This 
oligonucleotide was treated with the activated cerium(III) complex (3) in an 
aqueous solution of triethylammonium acetate, pH=6.0. After one hour at 
room temperature, the reaction mixture contained a single new 
oligonucleotide (12) which migrated through the gel more slowly than either 
(10) or (11), consistent with the addition of molecular weight and positive 
charge (Figure 4.9, lane 4). Degradation of the RNA by excess cerium complex 
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Figure 4.9 (Top) Sequences and structures of oligoribonucleotides 9-12 with 
the synthesis scheme for the generation of (12), modified at its 5' end with the 
cerium(III) macrocyclic complex. (Bottom) Storage phosphor autoradiogram 
of the 20% polyacrylamide gel used to analyze the relative mobilities of 9-12. 
(Lane 1) Oligoribonucleotide (9) (Lane 2) Oligoribonucleotide (10) (Lane 3) 
Oligoribonucleotide (11) (Lane 4) Oligoribonucleotide (12). 
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(3) was minimized by running the reaction at room temperature, pH=6 for 
only one hour. Precipitation from the reaction mixture with ethanol and 
sodium acetate gave purified (12). 
When modified oligoribonucleotide (12) was incubated at 37°C for 8 
hours, no strand scission could be detected arising from transesterification 
promoted through intramolecular phosphodiester coordination by the 
attached metal complex (Figure 4.10, lane 7). When (12) was treated with 0.2 
mM complex (1) under the same conditions, cleavage at all nucleotide 
positions was detected, indicating that these phosphodiesters were reactive 
and these solution conditions supported the transesterification reaction. An 
RNA conjugate prepared with the lanthanum(III) complex gave identical 
results. lOb 
Modeling of the linker suggested that intramolecular coordination 
might occur at the 5' phosphodiester linking the oligonucleotide to the 
tethered complex. This phosphodiester does not have an adjacent 2' OH and 
therefore cannot undergo the transesterfication reaction. If coordination were 
to occur here, no cleavage would be detected. 
To determine if a different linker structure would direct the 
transesterification reaction to internal RNA phosphodiesters, a shorter linker 
without the 5' terminal phosphodiester was designed. For this purpose, a 5'-
deoxy-5'-S-trityl-uridine phosphoramidite was prepared. The synthesis was 
carried out based on the published synthesis for the 5'-deoxy-5'-S-trityl-
thymidine phosphoramidite, with an added step for the protection of the 
uridine 2 ' OH (Scheme III).15 Thus, 5'-deoxy-5'-iodouridine was protected at 
the 2'0H by reaction with t-butyldimethysilyl chloride in the presence of 
silver nitrate as described by Ogilvie for uridine analogs.16 Displacement of 
171 
Figure 4.10 Autoradiogram of the 20% denaturing polyacrylamide gel used to 
analyze transesterification reactions. The reactions were carried out by 
incubating 32p labeled (12) (7 ~M, 9000 cpm) in a solution of 50 mM Hepes, 
pH=7.5 for 14 H, 37°C in the presence or absence of 0.2 mM (1). (Lane 1-3) 
Oligoribonucleotide 9 (Lane 2) Alkaline hydrolysis products (Lane 3) 
Products of a reaction with C specific ribonuclease CL3 (Lane 4) 
Oligoribonucleotide (10) (Lane 5) Oligoribonucleotide (11) (Lanes 6-8) 
Oligoribonucleotide (12) (Lane 6) No incubation at 37°C (Lane 7) Incubation 
under the reaction conditions for 14H (Lane 8) Incubation under the reaction 
conditions in the presence of 0.2 mM (1) . 
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iodide by the sodium salt of trityl mercaptan followed by phosphitylation 
gave the necessary protected phosphoramidite (16). 
a[_ 13 R1=1, R2=H 
14 R1 =1, R2=0TBDMS 
~ 15 R1=Tr5, R2=0fBDMS 
16 
Scheme III a) TBDMSCl, AgN03, THF, pyridine; b) TrSNa, DMF; c) 2-
cyanoethyl N, N-diisopropyphosphoramidous chloride, DMAP, THF. 
Oligoribonucleotides (17-20) were prepared to test the effect of changing 
the structure of the linker connecting the cerium(III) complex to the RNA. 
Oligoribonucleotide (18) was generated by automated RNA synthesis using 
standard procedures with phosphoramidite (16) employed in the last coupling 
step. Deprotection and purification of the RNA was carried out as before. 
Oligoribonucleotide (17) was prepared as a size marker for electrophoresis 
analyses. Oligoribonucleotides (17) and (18) were 3' end 32p labeled by 
established procedures.14 Detritylation and conjugation proceeded as 
described for (12) to generate modified oligoribonucleotide (20) (Figure 4.11). 
Again, upon incubation of (20) at 37°C, no cleavage corresponding to 
transesterfication could be detected. An RNA conjugate prepared with the 
lanthanum(III) complex gave identical results.10b Interestingly, even though 
all the phosphodiesters in the molecule had adjacent 2' OH nucleophiles, no 
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Figure 4.11 Sequences and structures of oligoribonucleotides 17-20 
with the reaction scheme for the generation of (20) modified at its 5' 
end with the macrocyclic cerium(III) complex. 
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self-cleavage was apparent. Therefore, if intramolecular coordination were 
occurring, it was in a mode which did not lead to transesterfication. 
Over a 48 H incubation at 37°C, a slow decomposition reaction to a 
material which migrated through the gel more rapidly than (20) was detected. 
However, this product was not the result cleavage of one of the 
internucleotide phosphodiesters (Figure 4.12). The presence of EDTA at 1 
mM concentration accelerated the rate of this decompostion reaction by 
approximately a factor of 2.17 The gel mobility of the decomposition product 
and the rate acceleration by EDTA is consistent with demetallation of the 
cerium(ill) complex. This correlates with the observations of Morrow and co-
workers that the polycarboxylate chelator EGTA accelerates the decomposition 
of lanthanide complexes of the type L•Ln+3, where Lis the macrocylic ligand 
in Figure 4.4 with R= methyJ.6f 
Conclusions and Prospectus 
Methods for covalent attachment of the hexadentate Schiff-base 
macrocyclic cerium(III) complex (1) to oligodeoxyribo- and 
oligoribonucleotides have been developed. However, no success has been 
made in directing the transesterification reaction promoted by (1) using these 
modified oligonucleotides. Interestingly, RNA binding peptides modified 
with a hexadentate Schiff-base macrocyclic lanthanum(III) complex have been 
shown to direct the transesterification reaction of specific phosphodiesters in 
a bound RNA.10b Therefore, it appears that the structure of the RNA binding 
molecule may be a key factor in determining the success of a directed reaction. 
The precise reason for our inability to direct the reaction of (1) by 
covalent attachment to RNA binding oligodeoxyribonucleotides or to the 
176 
Figure 4.12 Autoradiogram of the 20% denaturing polyacrylamide gel used to 
analyze transesterification reactions. The reactions were carried out by 
incubating 32p labeled (20) (0.1 11M, 120 kcpm) in a solution of 10 mM TrisHCl 
pH=7.2, 70 mM NaCl at 37°C with or without 1 mM EDTA in a total volume 
of 160 IlL At various times, 30 IlL of the reaction mixture was removed and 
the reaction was stopped by ethanol precipitation and products were analyzed 
by gel electrophoresis. (Lane 1) Oligoribonucleotide (18) (Lanes 2 and 3) 
Oligoribonucleotide (17) (Lane 2) Untreated (17) (Lane 3) Alkaline hydrolysis 
products (Lanes 4-14) Oligoribonucleotide (20) (Lanes 10-14) EDTA, 1 mM 
(Lane 4) Untreated (20) (Lanes 5 and 10) 0 hours (Lanes 6 and 11) 8 hours 
(Lanes 7 and 12) 16 hours (Lanes 8 and 13) 32 hours (Lanes 9 and 14) 48 hours 
Arrows at right indicate the mobility of oligoribonucleotide 20 (top) and the 
degradation product (bottom). 
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oligoribonucleotide itself is not clear at this time. Studies designed to define 
the role of the lanthanide ion/ complex in the reaction mechanism would aid 
further experiments. Also, given the crystal structure of (1) bound to 
dimethylphosphate discussed previously, it is possible that more than one 
metal ion per phosphodiester is required to promote the reaction. Therefore, 
the development of RNA binding molecules containing more than one 
metal complex may be necessary. 
Experimental Section 
General. lH NMR spectra were recorded on a General Electric-QE 300 NMR 
spectrometer. High resolution mass spectra were recorded using fast atom 
bombardment (FAB) at the Mass Spectrometry Facility at the University of 
California, Riverside. Preparative reverse phase chromatography was 
performed using a Pharmacia FPLC system with UV detection at 254 nm. E. 
Merck silica gel 60F (0.25mm) and Whatman KC18F reverse phase plates were 
used for analytical thin layer chromatographic monitoring of reactions. Flash 
chromatography was executed with E. Merck silica gel (230-400 mesh). 
Ultraviolet spectra were obtained with a Hewlett Packard 8452A Diode Array 
Spectrometer. All reagents and solvents were purchased from Aldrich and 
used without further purification unless otherwise noted. Distilled, 
deionized water was used for all aqueous reactions and dilutions. Macrocyclic 
cerium(III) complex (1) was prepared as decribed by Abid and Fenton.18 The 
substituted macrocyclic cerium(III) complex (2) was prepared via the eight step 
synthesis of Carriera and Dervan from cheladamic acid.ll The 3-(2-
pyridyldithio)propionic acid N-hydroxysuccinimide ester was prepared as 
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described by Carlsson et al. in two steps from 3-mercaptopropionic acid.19 S-
Trityl-3-mercaptopropanol was prepared via the one step procedure of 
Connolly and Rider from 3-bromopropan(l)oL12 5'-Deoxy-5'-iodouridine 
was prepared as described by Verheyden and Moffatt in two steps from 2',3'-0-
isopropylideneuridine.20 Tetrahydrofuran (THF) was distilled under 
nitrogen from sodium/benzophenone ketyl. Dichloromethane (DCM), 
triethylamine (TEA), diisopropylethylamine (Hunig's base) and pyridine were 
distilled under argon from calcium hydride. Dry DMF was purchased from 
Fluka. 2'-3'-0-Isopropylideneuridine was purchased from Spectrum. DNA 
phosphoramidites were purchased from Applied Biosystems. RNA 
phosphoramidites were purchased from BioGenex Laboratories (San Ramon, 
CA). Polyacrylamide gel electrophoresis was performed using 1XTBE buffer 
unless otherwise noted. 5'-(y-32p)ATP (>5000 Ci/mmol) and 5'-(32P-pCp)-
3'(3000 Ci/mmol) were obtained from Amersham. 5' and 3' end labeling was 
executed using standard procedures. Nonldet P-40 detergent was purchased 
from Sigma. Cerenkov radioactivity was measured on a Beckman LS 2801 
scintillation counter. 
Hexadentate Shiff-base macrocyclic cerium(III) complex (3). Amine (2) (20 mg, 
0.025 mmol) was dissolved in 0.163 mL 100 mM triethylammonium acetate, 
pH = 7.6 . To this solution was added a solution of 3-(2-
pyridyldithio)propionic acid N-hydroxysuccinimide ester (23 mg, 0.075 mmol) 
in 0.081 mL acetonitrile. The reaction was shaken at room temperature for 40 
min. The resulting suspension was diluted into 250 mM ammonium acetate, 
pH = 4.7, and filtered. The product was purified by reverse phase 
chromatography using a Pharmacia FPLC system with a C8 ProRPC 10/10 
column and a gradient of 0-65% acetonitrile over 40 minutes in 250 mM 
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ammonium acetate, pH = 4.7. The solvent was removed by lyophilization to 
give 6 mg of (2), 24%. 1 H NMR (D20, 300 MHz) 14.8 (s, 2H), 14.4 (s, 2H), 10.9 
(m, 3H), 10.5 (s, 2H), 7.9 (d, 1H, J= 4.5 Hz), 7.7(d, 1H, J= 7.8 Hz), 7.5 (t, 1H, J= 7.8 
Hz) 6.9 (m, 1H), 6.0 (s, 2H), 3.8 (m, 2H), 3.7(m, 2H), 3.1(t, 2H, J= 6.3 Hz), 3.0 (br s, 
4H) 2.8(t, 2H, J= 6.3 Hz), 2.6 (br s, 4H), 1.1 (s, 9H). FABMS [M+3-2Ac-]+ calcd for 
C34H39N907S2Ce: 889.147, found 889.143. 
S-Trityl-0-N,N-diisopropyl-(3-cyanoethylphosphoramidite-3-mercaptopropan 
(l)ol (5). To a solution of 5-Trityl-3-mercaptopropanol (0.36 gm, 1.08 mmol) 
and TEA (0.263 mL, 1.98 mmol) in 10 mL freshly distilled DCM was added 2-
cyanoethyl N,N-diisopropylphosphoramidous chloride (0.20 mL, 0.9 mmol 
via syringe. The solution was stirred at 0° C under argon for 30 min. The 
reaction mixture was diluted with DCM and washed with saturated 
N aHC03(aq)· The aqueous fraction was collected and washed with additional 
DCM. The organic fractions were combined, dried(Na2S04), filtered and 
concentrated. The product was purified by flash chromatography on silica gel 
with an 4:1 solution of hexane and diethylether containing 1% TEA. The 
solvent was removed in vacuo to give 0.412 gm of (3) as a yellow oil, 85%. 1H 
NMR (CDCl3, 300 MHz) o 7.4-7.2 (m, 15H), 3.8 (m, 2H), 3.6 (m, 4H), 2.6 (t, 2H, 
J= 6.3 Hz), 2.2 (t, 2H, J= 7.4 Hz), 1.6 (m, 2H), 1.1-1.2(m, 12 H) FABMS [M-H]+ 
calcd for C31H3802N2SP: 533.239, found 533.241. 
Synthesis and purification of S-Trityl-oligodeoxyribonucleotide (6). 5-Trityl-
oligodeoxyribonucleotide (6) was prepared on an Applied Biosystems Model 
380B DNA synthesizer with (3-cyanoethyl phosphoramidites. The protected 
thiol functionality was incorporated into the oligonucleotide via the coupling 
of phosphoramidite (5) as the last step in automated synthesis. Base labile 
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protecting groups were removed by treatment of the oligonucleotide with 
concentrated Nfl40H at 55°C for 24 H . Purification was carried out by reverse 
phase chromatography using a Pharmacia FPLC ProRPC 10/10 (C2-C8) 
column with a 0-40% CH3CN gradient in 100 mM triethylammonium acetate, 
pH=7. Phosphoramidite (5) was estimated to have coupled with an efficiency 
of >90% based upon the amount of the n-1 byproduct seen during 
purification. Chromatography solvent was removed by lyophilization. The 
resulting residue was dissolved in water and lyophilized further. The 
oligonucleotide was quantitated by determining the concentration in aqueous 
solution by UV spectroscopy at 260 nm, using the following molar extinction 
coefficients for each base: 15400 (A), 11700 (G), 7300 (C) 8800 (T) cm-lM-1. The 
solutions were lyophilized and the resulting oligonucleotide was stored as dry 
solid in 4-5 nmole fractions at -20° C. 
Generation of the oligodeoxyribonucleotide-hexadentate Schiff-base 
macrocyclic ceriumUII) complex conjugate (8). To remove the S-trityl 
protecting group, (6) (0.03 JJ.mol in 30 JJ.L 100 mM TEAA, pH=6.5) was treated 
with a solution of silver nitrate (5 JJ.mol in 5 JJ.L H20). This reaction was 
shaken at room temperature for 30 min. Dithiothreitol (DTT) (6.4 JJ.mol in 6.4 
JJ.L H20) was added and the reaction was shaken an additional 5 min. at room 
temperature, at which time the precipitated Ag+ salt was removed by 
centrifugation. The precipitate was washed with 60 JJ.L of 100 mM TEAA, 
pH=7.6 and centrifuged again. The supernatants containing oligonucleotide-
thiol (7) and excess DTT were combined. HPLC analysis of this solution 
indicated complete deprotection of the oligonucleotide. DTT was removed by 
extraction six times with an equal volume of H20 saturated ethyl acetate. The 
resulting solution of (7) in 100 mM triethylammonium acetate was adjusted 
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to pH=7.0 with a 0.5 M solution of triethylammonium acetate, pH=7.6. To 90 
J!L of this solution containing 0.027 J.Lmol (7) was added 50 J!L of an aqueous 
solution containing 0.090 J.Lmol of pyridyldisulfide (3). The reaction was 
allowed to proceed for 1 Hat room temperature with periodic shaking. HPLC 
analysis of the reaction solution after 1 H indicated complete conversion of (7) 
to a single new oligodeoxyribonucleotide (8). This compound was purified by 
precipitation twice from an aqueous solution containing 85 mM sodium 
acetate and 70% ethanol at -20°C for 15 min. The precipitate was washed with 
70% ethanol and briefly dried in vacuo. This compound was stored as a dry 
pellet in 5 nmole aliquots at -20°C. Periodic HPLC analysis showed that 
conjugates prepared by this technique are unchanged for weeks at -20°C. 
However, incubation under reducing conditions (DTT) will regenerate the 
thiol containing oligonucleotide starting materials. 
HPLC Analysis. Analytical HPLC was performed with a Hewlett-Packard 1090 
liquid chromatographer fitted with a diode array detecter using a Brownlee 
Labs Aquapore OD-300 4.6 mm x 22 em, 7-J.Lm C18 column. A gradient of 0-
65% acetonitrile in 100 mM ammonium acetate, pH=4.7 over 40 min. was 
employed. Typically 1-5 nmoles of oligonucleotides and 0.05-0.1 J.Lmoles of (3) 
was used for each chromatogram. 
Synthesis and purification of oligoribonucleotides. RNA synthesis was 
carried out on an Applied Biosystems 394 DNA and RNA synthesizer using 
2'0TBDMS-f3-cyanonethyl phosphoramidites protected at the base with 
phenoxyacetyl(P AC) for r A and rG and benzyl (Bz) for rC. Base labile 
protecting groups were removed by treatment with ammonia saturated 
methanol for 24 H at room temperature. Silyl protecting groups were 
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removed by treatment with 0.1 M tetrabutylammonium fluoride in THF for 
24 Hat room temperature. The solvent was removed by lyophilization and 
the resulting material was redissolved in H20 and lyophilized further. Excess 
salts were removed by dialysis of an aqueous solution of this material against 
10 mM TrisHCl, pH=7.3 for 48 H followed by an 8 H dialysis against H20. The 
resulting solution was filtered and lyophilized. The oligoribonucleotide was 
dissolved in formamide TBE loading buffer and loaded onto a 15% 
polyacrylamide gel for purification by electrophoresis.1 The gel bands were 
visualized by UV shadowing and excised. RNA was extracted from the gel 
slice in an aqueous 0.05% Nonidet P-40 solution at room temperature for 1-4 
H and the resulting suspension was filtered. Ethanol precipitation from 85 
mM sodium acetate followed by washing with 70% ethanol and drying in 
vacuo provided the purified oligoribonucleotide. The RNA was quantitated 
by determining the concentration in aqueous solution by UV spectroscopy at 
260 nm, using the following molar extinction coefficients for each base: 15400 
(A), 11700 (G), 7300 (C) 9900 (U) cm-lM-1. The solutions were lyophilized and 
the resulting oligonucleotide was stored as dry solid in 2 nmole fractions at 
-20° c. 
Transesterification reactions. In a typical set of transesterfication reactions, 
labeled RNA was added to a solution of buffer (Tris or Hepes) and salt (NaCl 
or NaN03) and this solution was allowed to equilibrate briefly. The 
hexadentate Shiff-base macrocyclic cerium (III) complex (1), modified 
oligodeoxyribonucleotide or unmodified oligodeoxyribonucleotide at various 
concentrations was added and the reaction was allowed to incubate at various 
temperatures for various time intervals. At the end of the incubation period, 
the RNA was precipitated by the addition of ethanol and sodium acetate and 
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chilling to -20°C for 15 min. The precipitate was isolated by centrifugation and 
washed with 70% ethanol and dried briefly in vacuo. The resulting pellets 
were dissolved in formamide TBE loading buffer and the RNA was 
fractionated by 20% polyacrylamide gel electrophoresis. Gel bands were 
visualized by autoradiography by exposure to X-ray film (Kodak) at -70° C 
with an intensifying screen or by phosphor storage autoradiography. 
Storage Phosphor Autoradiography. Storage phospor imaging plates (Kodak 
Storage Phosphor Screen S0230 obtained from Molecular Dynamics) were 
pressed flat against gel samples and exposed in the dark for 12-17 hours.21 A 
Molecular Dynamics 400S Phosphorlmager was used to obtain all data from 
the storage screens. 
Synthesis and purification of S-Trityl-oligoribonucleotide (10). Modified 
oligoribonucleotide (10) was prepared on an Applied Biosystems Model 394 
DNA and RNA synthesizer with 2'-0TBDMS-J3-cyanoethyl 
phosphoramidites. The protected thiol functionality was incorporated into 
the oligonucleotide via the coupling of phosphoramidite (5) as the last step in 
automated synthesis. This RNA oligonucleotide was deprotected and 
purified on a 20% polyacrylamide gel as described above for synthetic 
oligoribonucleotides. 
Generation of the llp labeled oligoribonucleotide-hexadentate Schiff-base 
macrocyclic cerium(III) complex conjugate (12). The S-trityl-
oligoribonucleotide (10) was 3' end labeled with RNA ligase and 5'-(32pCp)-3' 
according to published procedures. To remove the 5-trityl protecting group, 
3' end 32p labeled 10 (4.5 nmol, 210 kcpm in 24 J..lL H20) was treated with a 
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solution of silver nitrate (5 IJ.mol in 5 IJ.L H20). This reaction was shaken at 
room temperature for 30 min. Dithiothreitol (OTT) (6.4 IJ.mol in 6.4 IJ.L H20) 
was added and the reaction was shaken an additional 5 min. at room 
temperature, at which time the precipitated Ag+ salt was removed by 
centrifugation. The precipitate was washed with 30 IJ.L of 100 mM TEAA, 
pH=7.6 and centrifuged again. The supernatants containing oligonucleotide-
thiol (11) and excess DTT were combined. Analysis of the 32p labeled 
components of this solution by electrophoresis on a 20% polyacrylamide gel 
indicated complete deprotection of the oligonucleotide. DTT was removed by 
extraction six times with an equal volume of H20 saturated ethyl acetate. The 
resulting solution of (11) in 50 mM triethylammonium acetate was adjusted 
to pH=6.0 with a 0.5 M solution of triethylammonium acetate, pH=7.6. To 36 
IJ.L of this solution containing 3.2 nmol, 148 kcpm (11) was added 20 IJ.L of an 
aqueous solution containing 0.036 IJ.mol of pyridyldisulfide (3). The reaction 
was allowed to proceed for 1 H at room temperature with periodic shaking. 
Electrophoretic analysis of the reaction solution after 1 H indicated complete 
conversion of (11) to a single new slower migrating labeled species (12). This 
compound was purified by precipitation twice from an aqueous solution 
containing 85 mM sodium acetate and 70% ethanol at -20°C for 15 min. The 
precipitate was washed with 70% ethanol and briefly dried in vacuo. This 
compound was stored as a frozen aqueous solution at 40 IJ.M, 2,500 cpm/ IJ.L at 
-20°C. 
Self cleavage experiments with 3Zp labeled oligoribonucleotide-hexadentate 
Schiff-base macrocyclic cerium(III) complex conjugates. In a typical self 
cleavage experiment, labeled RNA conjugate was removed for storage at 
-20°C and added to a solution of buffer (Hepes or Tris) and NaCl. The RNA 
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conjugate was incubated in this solution in the presence and absence of the 
cerium(III) complex (1) at various temperatures for various time intervals. 
At the end of the incubation period, the RNA was precipitated by the addition 
of ethanol and sodium acetate and chilling to -20°C for 15 min. The 
precipitate was isolated by centrifugation and washed with 70% ethanol and 
dried briefly in vacuo. The resulting pellets were dissolved in formamide TB 
loading buffer (no EDTA) and the RNA was fractionated by 20% 
polyacrylamide gel electrophoresis in 1XTB buffer (no EDTA). Gel bands were 
visualized by autoradiography by exposure to X-ray film (Kodak) at -70° C 
with an intensifying screen or by phosphor storage autoradiography. Specific 
reaction conditions are given in the figure legends. 
5'-Deoxy-5' -iodo-2' -0-tertbutyl dimethylsilyl-uridine (14). 5'-Iodouridine (13) 
(1.78 gm, 5 mmol) was dissolved in 50 mL freshly distilled THF and 2.2 mL 
dry pyridine was added. Silver nitrate (1.7 gm, 10 mmol,) was added and the 
suspension was stirred until most of the silver nitrate had dissolved. t-
Butyldimethylsilyl chloride (1.36 gm, 9 mmol) was added and the resulting 
suspension was stirred at room temperature under argon for 5.5 H. The 
reaction was filtered and the filtrate was diluted into DCM. This solution was 
washed with 5% NaHC03(aq)· The fractions were partisioned and the 
aqueous fraction was further washed with DCM. The organic fractions were 
combined, dried (Na2S04), filtered and concentrated. The product was 
purified by flash chromatography on silica gel with a 1:1 solution of ethyl 
acetate and petroleum ether. The solvent was removed in vacuo to give 1.77 
gm of (7) as a white foam, 75%. 1 H NMR (CDCl3, 300 MHz) B 8.6 (br s, 1H), 7.6 
(d, 1H, J= 8.1 Hz), 5.9-5.8 (m, 2H), 4.4 (m, 1H), 4.0-3.9 (m, 2H), 3.6-3.5 (m, 2H), 
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0.95 (s, 9H), 0.15 (s, 6H) FABMS MH+ calcd for C15H260SN21Si 469.066, found 
469.064. 
S-Trityl-5'-deoxy-5'-thio-2'-0-tertbutyldimethylsilyl-uridine (15). A 60% 
dispersion of NaH in mineral oil (136 mg, 3.4 mmol) was suspended in 5 mL 
dry DMF under argon. The suspension was cooled to 0° C and a 25 mL DMF 
solution of triphenylmethylmercaptan (1.56 gm, 5.66 mmol) was added. This 
solution was stirred at room temperature for 10 min., at which time it was 
cooled on an ice bath and a 20 mL DMF solution of (14) (1.77gm, 3.77 mmol) 
was added. The solution was stirred at 0°C for 30 min. The reaction was 
diluted into a mixture of 5% NaHC03(aq) and DCM and extracted. The 
aqueous fraction was washed with DCM and the organic fractions were 
combined, dried (Na2S04), filtered and concentrated. The product was 
purified by flash chromatography on silica gel with a 3:2 solution of hexane 
and ethyl acetate. The solvent was removed in vacuo to give 1.19 gm of (15) 
as a white foam, 51%. lH NMR (CDCl3, 300 MHz) 8 8.3 (br s, lH), 7.5-7.2 (m, 
16H), 5.7 (m, 2H), 4.1 (m, lH), 3.7 (m, lH), 3.8 (m, lH), 2.7 (m, lH), 2.5 (m, lH), 
0.91 (s, 9H), 0.09 (s, 3H), O.ll(s, 3H) FABMS [M-H]+ calcd for C35H3905N2SSi: 
615.235, found 615.235. 
S-Trityl-5'-deoxy-5'-thio-3'-0-(2-cyanoethyl-N,N-diisopropylphosphor 
amidite)-2'-0-tertbutyldimethylsilyl-uridine (16). To a stirred solution of 
Hunig's base (0 .17 mL, 0.972 mmol), 2-cyanoethyl N ,N-
diisopropylphosphoramidous chloride (0.071 mL, 0.316 mmol) and DMAP (6 
mg, 0.049 mmol) in 1 mL freshly distilled THF (Na, benzophenone) was 
added dropwise a solution of (15)(0.15 gm, 0.243 mmol) in 1 mL THF. The 
solution was stirred under argon at room temperature for 3.5 H, at which 
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time the reaction was complete as indicated by analysis using C18 reverse 
phase TLC with an 85% acetonitrile in H20 mobile phase. The reaction was 
diluted into ethyl acetate and this solution was extacted four times with 
saturated NaCl(aq)· The organic fraction was dried (Na2S04), filtered and 
concentrated. The product was purified by flash chromatography on silica gel 
using a solution of 3:2 to 1:1 petroleum ether and ethyl acetate with 1% 
triethylamine. The solvent was removed in vacuo to yield 0.109 gm of (16) as 
a white foam, 55%. 1 H NMR (CDCI3, 300 MHz) o 8.5 (br s, 1H), 7.4-7.2 (m, 
17H), 5.7 (m, 2H), 4.2 (m, 2H), 4.9-3.5 (complex m, 5H), 2.7-2.4(complex m, 4H), 
1.2-1.1(m, 13H), 0.9 (s, 9H), 0.8 (m, 6H) FABMS MH+ calcd. for 
C43H5806N4SSiP: 817.358, found 817.354. 
Synthesis and purification of S-Trityl-oligoribonucleotide (18). Modified 
oligoribonucleotide (18) was prepared on an Applied Biosystems Model 394 
DNA and RNA synthesizer with 2'-0TBDMS-J3-cyanoethyl 
phosphoramidites. The protected thiol functionality was incorporated into 
the RNA via the coupling of phosphoramidite (16) as the last step in 
automated synthesis. This RNA oligonucleotide was deprotected and 
purified on a 20% polyacrylamide gel as described above for synthetic 
oligoribonucleotides. Phosphoramidite (16) was estimated to have coupled 
with an efficiency of -70% based upon the amount of the n-1 by product seen 
during purification. 
Generation of the 31.p labeled oligoribonucleotide-hexadentate Schiff-base 
macrocyclic cerium(III) complex conjugate (20). The 5-trityl-
oligoribonucloetide (18) was labeled, detritylated and conjugated to the 
macrocylic metal complex as described for (12) with slight modification. The 
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conjugation reaction for (20) was carried out at pH=6.5 for 2 H. The final 
disulfide product was purified on a 20% polyacrylamide gel. Isolation from 
the polyacrylamide gel was carried out as described for the synthesis and 
purification of ribonucleotides. 
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